---
id: 3781342b836d8582
title: Textbook Natural Medicine Part6
source: HR Knowledge
year: 1801
book_type: guide
language: en
original_format: pdf
topics:
- herbalism
- botany
- longevity
- lifestyle
- nutrition
tags:
- HR Knowledge
- textbook
rag_version: v1
---

# Textbook Natural Medicine Part6

Mood exercise for, 291–292 galactooligosaccharides and, 804–805 polyunsaturated fatty acids and, trans fatty acids and, Morbid symptoms, Morbidity, 1605–1606, 1606b “Morphogenetic field”, Morphology, of sperm, 1455t–1457t Morus indica (mulberry plant), 1281, 1281t Motherwort (Leonorus cardiaca), Motility, of sperm, 1455t–1457t Motor function, Mouth, pain, Movement, new perspective in, standards of, 283–288 MPTP. See 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine MRI. See Magnetic resonance imaging MRSA. See Methicillin-resistant Staphylococcus aureus MS. See Multiple sclerosis MST. See Multisugar test MTBE. See Methyl tert-butyl ether MTHFR. See 5,10-methylenetetrahydrofolate reductase MTHFR gene, MTR. See Methionine synthase MTR reductase, MTs. See Metallothioneins Mucolytics, for pneumonia and bronchitis, Mucosal factors, in excretion of sugar probes, Mucosal immune system, food allergies and, Mucosal immunoglobulin A (IgA), for asthma, Mucosal protectors, Mucuna pruriens (velvet bean), Mukul myrrh tree. See Commiphora mukul Mulberry plant (Morus indica), 1281, 1281t Multimineral formula, for inflammatory bowel disease, 1482, 1482t Multiple chemical sensitivities (MCS), 1227–1228 Multiple sclerosis (MS), 1587–1599.e3, botanical medicines for, brain image, 1588f considerations for, 1587–1590, 1588t diagnosis of, 1587, 1590–1591, 1591t diet and supplements for, 1594–1598 epidemiology of, exercise for, 1597–1599 mind-body intervention, natural medicine for, nutritional supplements for, 1595–1597, pancreatic enzymes for, pathogenesis of, 1588–1589 risk factors for, 1589–1590 diet, 1589–1590 environment, 1589–1590 genes, geographical and seasonal influences, gut microbiome, infections, toxins and toxicants, stress and, management therapy, reduction, therapeutic considerations/approaches for, 1591–1599 Multiplex sIgE testing, Multisugar test (MST), 170–171 limitations of, Multivitamins, for inflammatory bowel disease, 1482, 1482t, Murphy, L. R., Musa sapientum var. paradisiaca (plantain), Muscle atrophy, 1801–1802 Muscle cramping, 499–500 Muscle relaxants, Muscle strains, hamstring, Muscles abnormal end-feel, changes with hypothyroidism to, differentiation, fish oils for health of, nocturnal myoclonus, 1491–1492 regeneration, strength assessment, 1789–1790 Muscular dystrophies, coenzyme Q 10 for, 533–534 Muscular end-feel, Mushrooms ASD and, yeast problem with, Mutagenicity, mVOCs. See Microbial volatile organic compounds My Water Cure (Kneipp), Mycobacterium tuberculosis, Mycology, Mycotoxin exposure, 1026–1034.e3 common, 1029–1030 aflatoxin, gliotoxin, ochratoxin, 1030, 1030f fungi, 1026, 1028t methods of assessment, 1030–1031 ELISA, liquid chromatography-MS/MS, 1031, 1032f mold species, Aspergillus, Fusarium, Penicillium, Stachybotrys, symptoms of, 1026, 1027f treatment, 1031–1034 antioxidants, 1032–1033 avoidance and remediation, 1031–1032 excretion and detoxification, 1032, 1033f fungal, 1033–1034, 1033f Mycotoxins definition of, from WHO, from toxic molds, 210t urinary levels of, 211, 213t Myocardial infarction (MI), 97, 494, 601–602, 963–964 Myoclonus, nocturnal, 1491–1492 Myofascial pain dysfunction, Myofascial trigger points, Myokines, Myopathy, peat therapy for, Myostatin as negative regulator of muscle mass, sarcopenia, 1792–1794 MyPlate, Myrtle berry,

# N

NA. See Nervonic acid N-acetylcysteine (NAC), 1073–1075, as antioxidants, for chronic kidney disease, for endometriosis, for HIV/AIDS, 1385b for pneumonia and bronchitis, N-acetylglucosamine, glucosamine sulfate versus, 629–630, 630f NADA. See National Acupuncture Detoxification Association NADH. See Nicotinamide adenine dinucleotide NAET. See Nambudripad’s Allergy Elimination Tech- niques NAFLD. See Nonalcoholic fatty liver disease Nail changes, with hypothyroidism, Nail infections, fungal, Melaleuca alternifolia (tea tree) for, Nambudripad’s Allergy Elimination Techniques (NAET), 139 Narcolepsy, Nasal saline, for bacterial sinusitis, Nasal steroids, for bacterial sinusitis, National Acupuncture Detoxification Association (NADA), National Association of Naturopathic Physicians, National Asthma Education and Prevention Program (NEAPP), 1119t National Board of Naturopathic Examiners of the ANA, 40 National Certification Commission for Acupuncture and Oriental Medicine (NCCAOM), 251–252, National Chiropractic Association (NCA), National Chiropractic Journal, The, National College of Chiropractic, 41–42 National College of Naturopathic Medicine, National Cooperative Crohn’s Disease Study (NCCDS), 1475–1476 National Health and Nutrition Examination Survey (NHANES), trial, National Institutes of Health (NIH), National Toxicology Program (NTP), Natrum muriaticum, Natura medicina, 69–71 Natural eggshell membrane (NEM), 1626–1627 Natural healing, 26–31 Natural killer (NK) cells, 94, 163, Natural living laws, Natural medicines, categories of, Natural medicines quality control, 722–730.e1 abbreviations and definitions in, buying decision, comprehensive testing, 726–727 contaminant testing, 725–726 economically motivated adulteration and, 722, importance of, 724–725 laboratory testing and laboratory quality, 727–728 product expiration date, stability testing, state of the industry, 722–723 supplier certification and skip lot testing, Natural substances, 23–24 Nature, 19b, versus nurture, 140–141, Nature, Nature Cure (Lindlahr), 52, Nature Cures: The History of Alternative Medicine in America, Nature Cures (Whorton), Nature’s Healing Agents: The Medicines of Nature, Nature’s healing order, 21b Nature’s Path, Naturopath, Naturopath and Herald of Health, The, 25, 32, Naturopathic Institute and Sanatorium of California, 37–38 “Naturopathic Legislation and Education”, Naturopathic medicine, 11, acute and chronic concerns in, allostatic model, 18b AMA and President Truman, beginning of, 49–51 beginning of the end, 69–73 back to education, 69–71 back to Texas, 71–73 Texas medical wars, conflicts in, decision making in, definition of, 13, directory of drugless physicians, early 20th century of, 51–52 Benedict Lust, drugless healing, 51, nature cure and vital force, naturopathy and chiropractic, 51–52 the end, 73–79 1955 to 1957, back to Texas medical wars, 75–76 dismal state of affairs, finished at WSC, 74–75 Florida saga begins, 77–78 part 2, Utah, Washington State under siege, 78–79 enter the class of 1953, 60–61 firming the curriculum, Foundations of Naturopathic Medicine Institute, genesis of post-WWI professionalism of, 52–55 evolution of profession, 53–54 leader of NDs in Washington, 54–55 short course in medical dominance, 52–53 time to build a profession, headwinds, 62–67 more basic science, 64–65 and repercussions, revisiting basic science, and scandals, 63–64 healing process in, 16f history of, 48–79.e4, 11–12 American Medical Association, 40–44

# I-34INDEX

Naturopathic medicine (Continued) convergence with American influences, 36–38 conversion to naturopathy, decline in U.S., early-20th-century medicine, 38–44 emergence of, founding of, 31–38 Germanic influence on, 35–36 History of Naturopathic Medicine, illness and healing as process in, Integration Project, long-term health strategies in, 17b Lust’s invention of, 11, 48. See also Lust, Benedict. magazines and textbooks on, meaning of disease, 83–84 mechanism, 80–81 medical philosophy in, 80–84 merging of efforts, 56–57 modern rejuvenation of holistic approach, 44–46 modern theory/process of development, 13–15 moving on, national scene, natural healing at its peak, 55–62 credit to Budden and Carroll, education, 55–56 vital force, 55–56 naturopathic philosophy in, 84–86 new developments in postwar scholarship, 57–58 at peak, 67–69 1947-1950 and forward, 67–68 after the scandals, change of identity, late 1940s and professional growth, medical dominance arises, 68–69 in memoriam, pharmaceuticals use by, pharmacologic treatment, philosophy of, 80–86.e1 physician in, practice of, 85–86 predictions of demise of, a profession, program of naturopathic cure, 34–35 public and community health concerns, 19b states/provinces that regulate, 46b “The Need for a New Medical Model” (Engel), theory in, therapeutic progression (Lindlahr’s), 12–13, Turska’s formula, 21st century state of, 46–47 vis medicatrix naturae, 84–85 vitalism, 80–81 Naturopathic Society of America, Naturopaths Lust’s description of, prosecution of, use of hydrotherapy by, worldwide numbers of practitioners, 39–40 Naturopathy and chiropractic, 51–52 in cross hairs, 72–73 definition of, Nausea Cannabis for, 475–476 Zingiber officinale (ginger), Nausea and vomiting of pregnancy (NVP), NCA. See National Chiropractic Association NCCAOM. See National Certification Commission for Acupuncture and Oriental Medicine NCCDS. See National Cooperative Crohn’s Disease Study NEAPP. See National Asthma Education and Prevention Program Necrospermia, 1454t “The Need for a New Medical Model” (Engel), Needs, Maslow’s Hierarchy of, 103, 103f “Negative” Studies, Neisseria gonorrhoeae, causing pelvic inflammatory disease, NEM. See Natural eggshell membrane Neoplasia, Maitake for, Neoplastic tissue, blood group antigen (BGA), expression in, 353t Nephrocalcin, Nephrotic syndrome (NS), coenzyme Q 10 deficiency and, Nervonic acid (NA), 130–131 Nervous system autonomic nervous system, central nervous system, manipulation of neural structures, parasympathetic nervous system, peripheral nervous system, sympathetic nervous system, Neural reflex, for overactive bladder, Neural tube defects (NTDs), Neurodegeneration berries for, curcumin for, vitamin C for, Neurodegenerative disease, fish oils for, 607–608 Neuroendocrinology dysfunction, of hypothalamic-pitu- itary axis, Neurogenic bladder, Neuroinflammation, 276–277 Neurological disease alpha-lipoic acid for, Cannabis for, 476–477 grape seed for, impact of homocysteine metabolism on, neuroprotective effects of Curcuma longa, Neuromuscular function, loss of, Neuromuscular manipulation, Neuropathy, 1274, diabetic, Neuropeptides, 94, 1757–1758 Neurophysiology, Neuroprotection cocoa for, resveratrol for, Neurotoxic chemicals, 1298–1299 Neurotoxicity, 274–277, 275b heavy metal, indirect (neuroinflammation), 276–277 pesticide, 275–276 Neurotransmitters, 6, Neutral baths, Neutropenia, Neutrophils, New Dietetics (Kellogg), New England Journal of Medicine, inadvertent provings, 308 New Guide to Health, “New York Hygio-Therapeutic College”, New York Medical Society, New York School of Massage, NHANES. See National Health and Nutrition Examina- tion Survey Niacin (vitamin B 3 ), status determination of, Niacinamide (nicotinamide), 1060, 1266, 1278, 1627, Nicotinamide adenine dinucleotide (NADH), 1233, 1671, 1673 Nicotine withdrawal, melatonin in, Nigella sativa (black cumin), for male infertility, 1471–1472 Night pain, NIH. See National Institutes of Health Nijmegen questionnaire, 1004–1005, 1005f Nipple, Nitric oxide, Nocebo effect, 89b, Nociception, pain related to, Nocturnal myoclonus, 1491–1492 Nonalcoholic fatty liver disease (NAFLD), 1600–1604.e3 chemicals and, 1602–1603 considerations for, 1600–1601 diagnosis of, 1600, prevalence of, 1601t probiotics and, psoriasis and, supplements for, therapeutic considerations/approaches for, 1603–1604, 1604f toxicity of, 1601–1603 Nonalcoholic steatohepatitis, 1600–1604.e3 melatonin for, Nonbioidentical hormones, Nonconvulsive seizures, 1296, 1297b Nondiabetic peripheral neuropathy, Nonmedical treatment, for acne vulgaris/acne conglo- bata, Nonradical oxidants, 732–733 Nonsmall cell lung cancer, melatonin for, Nonsmall cell metastatic lung cancer, melatonin for, Nonsteroidal antiinflammatory drugs (NSAIDs), 173, 1771 for asthma, kidney disease and, 1510, 1511f for urticaria, Nonulcer dyspepsia, Mentha piperita (peppermint) for, 714 Normal-transit constipation, Norwalk virus, 369, Nosebleed, NS. See Nephrotic syndrome NSAIDs. See Nonsteroidal antiinflammatory drugs NTDs. See Neural tube defects NTP. See National Toxicology Program Nuclear factor-κβ (NF-κβ, Curcuma longa and, Nuclear factor erythroid-2 related factor-2, Nuclear factor-κB, Nuclear p53 protein, Curcuma longa and, Nurbakhski, Nursing, Hypericum perforatum (St. John’s wort) and, Nutrient bioavailability, improvement of, microbial enzyme therapy for, 719–720 Nutrient deficiencies, in total load, Nutrient-drug interactions, Nutrient screening, 1459t Nutrients, for immune support/enhancement, Nutrigenetics for cardiovascular disease, 144–147 clinical applications of, 144–148 clinical utility of, 143–144 for electrolytes and hypertension, for homocysteine and micronutrients, 147–148, 147f overview of, 141–143, 141f personalized nutrition and, 144, 144f Nutrigenomics, 141–143, 141f, 359, 751, 1078–1079 clinical utility of, 143–144 Nutrition. See Diet/nutrition Nutrition and Cancer, Nutrition and Physical Degeneration (Price), Nutritional cognitive neuroscience, Nutritional medicine, 361–370.e1 anticancer phytochemicals, 367t diseases associated with low-fiber diet, 363b evolutionary aspects, 361–363 diet of wild relatives, 361–362, 362t humans versus primates, hunter-gatherer diets, pioneering work of Burkitt and Trowell, plant-based diet, 362–363 fat intake, food additives, foodborne illness, fruits and vegetables, meat/animal food intake, 367–368 nutrition education, 364–365 Optimal Health Food Pyramid, 364f–365f, 365–370 pesticides, metals, and food additives, 365–366 Rainbow Assortment of Fruits and Vegetables, 365, 366b salt and potassium, 368–369 support for blood sugar control, 366–367 U. S. Department of Agriculture Food Pyramid, 364f U. S. food consumption trends, 363–364, 363t–364t water intake, 369–370 Nutritional supplementation, in toxic overload, Nuts, ASD and, atherosclerosis and, 1137–1138 Nux vomica, NVP. See Nausea and vomiting of pregnancy Nystatin,

# O

O antigen, 346–347 OA. See Osteoarthritis OAB. See Overactive bladder Oatmeal, cholesterol and, 1139–1140 Obesity, 1605–1621.e3, alpha-lipoic acid for, body fat composition determination, 1606–1608, 1608t, 1608b bioelectric impedance,

# I-35INDEX

Obesity (Continued) bone density, skinfold thickness, 1607–1608 visual observation, 1606–1607 botanical medicines for, cancer and, 973, 973f causes of, 1609–1614, 1611f adipokines and gut-derived hormonal alterations, 1610 diet-induced thermogenesis, 1612, 1613f environmental toxins, 1613–1614, 1614f–1615f gut-derived appetite regulators, 1610–1612 low-serotonin theory, physiological factors, 1610–1614 psychological factors, 1609–1610 considerations for, diagnosis of, diet recommendations for, fasting and, female infertility and, Glycyrrhiza glabra (licorice), oral preparations con- taining glycyrrhizin, gout and, hypertension and, imbalance factors in, 5f interleukin-15 for, lifestyle changes for, male infertility and, NAFLD and, natural weight-loss aids for, 1617–1619 chromium, 1618–1619, 1619t detox support, 1620–1621, 1620f fiber supplements, 1617–1618, 1618t hydroxycitrate, 5-hydroxytryptophan, 1619–1620, 1620t meal-replacement formulas, medium-chain triglycerides, in PCOS, predisposition to gallstones and, prevalence of, 1605–1606, 1607f psychological support for, set point, therapeutic considerations/approaches for, 1614–1621 Atkins diet, 1616–1617 behavioral therapy, dietary strategies, 1615–1617 water intake, type 2 diabetes and, types of, 1608–1609 Obesity-related dyslipidemias, Obligatorily lytic phages, 779–780 Obstacles to cure, Obstructive sleep apnea, attention deficit hyperactivity disorder (ADHD) and, 1160 OCA. See Oregon Chiropractic Association Occupational agricultural exposure, to environmental toxins, Ochratoxin, 1030, 1030f Ocular rosacea, Oils, ASD and, Olea europaea (olive tree leaves), 1388b, Oleic acid (OA), Oligoasthenoteratozoospermia, 1454t Oligofructose, 797–798 Oligopolycyanidins, 545f Oligosaccharide intolerance, microbial enzyme therapy for, Oligozoospermia, 1454t Olive oil, atherosclerosis and, Olsen, K. G., Omega-3 fatty acids (linolenic acid), 593–612.e8, 586f, 591, 594f ASD and, atherosclerosis and, for diabetes management, for endometriosis, for hypertension, for multiple sclerosis, in pregnancy, 1735–1736 for psoriasis, for rheumatoid arthritis, sources of, Omega-3 index, Omega-3 polyunsaturated fatty acids, 129–130, 597, Omega-6, ASD and, Omega-6 fatty acids (linoleic acid), 129f, 586f, 594f linoleic acid/dihomo-gamma-linoleic acid ratio, for multiple sclerosis, Omega-6 (n-6) polyunsaturated fatty acids, Onion. See Allium cepa Ontology, in Unani medicine, Oocytes, Opioid pain medications, for osteoporosis, Opium, tincture of (laudanum), Optimal Health Food Pyramid, 1871, 1871f, 1872t beans (legumes), dairy, foods to avoid, fruits, high-quality protein, nutsseeds, and good oils, vegetables, 1871, green leafy and cruciferous, low-glycemic, starchy, whole grains, 1873, 1873t Opuntia species (prickly pear), for alcohol intoxication, analgesic effect of, antiinflammatory effect of, 752–753 antiviral effect of, chemical composition of, cicatrizant effect of, clinical applications of, 753–754 common names of, description of, 752, 753f for diabetes (adult-onset non-insulin-dependent), 753–754 diuretic and renal effects of, dosage of, drug interactions of, history and folk use of, for hyperlipidemia, hypocholesterolemic effect of, hypoglycemic effect of, 753, 753f for osteopenia, pharmacology of, 752–753 prediabetes, for prostatic hyperplasia, toxicology of, 754–755 for weight loss, Oral cavity abnormalities of oral membranes, nutrition-related, 223 burning sensation in, 224t cancer of, Candida albicans (candidiasis), HIV/AIDS treatment and, digestive physiology, erosions of, 224t gums, healthy mouth, signs of nutrient deficiency, 224t thrush, tongue, ulcers, 223, 224t Oral contraceptives, 151, 1215, 1680–1681 Oral health, Oral infections, Melaleuca alternifolia (tea tree) for, Oral mucosal disorders, Aloe vera (Cape aloe) for, 426–427 Oral tolerance, 227–228 Oregano essential oil (Origanium vulgare), 1858, 1859f Oregano oil, 1224–1225, Oregon Chiropractic Association (OCA), Oregon grape. See Berberis aquifolium Oregon Pioneer, Orexin A, Organ function, in total load, Organ specific stimulation, Organic acid profiling, 236–244.e6, 238t B-vitamin markers, carbohydrate metabolism β-hydroxybutyric acid, pyruvic acid and lactic acid, detoxification pathways, 243–244 Organic acid profiling (Continued) fatty acid oxidation, adipic acid, suberic acid, ethylmalonic acid, gut microbiota products, 236–239 in laboratory, 236–244 of mitochondrial dysfunction, 239–241 neurotransmitter metabolism, 241–242 vitamin-dependent pathways and, 242–243 Organic acid testing, 1039–1040, Organon of Medicine (Hahnemann), 22, Organophosphate pesticides, attention deficit hyperactivity disorder (ADHD) and, 1158 in infertility, Organophosphates, 218t–219t, 221, 221f, Organs/body systems complaint profile for chronic fatigue syndrome, 1231b cortisol effect on, damage to, distribution of carotenes/carotenoids in tissues, 445t Organ-system interventions, in functional medicine matrix model, Origanum majorana (marjoram), for PCOS, Oropharyngeal flora, Orotic acid, 243–244 Orthodox medical men, Orthodox medicine, Orthomolecular medicine, Orthosiphon grandiflorus, Orthotics, Osler, William, Osteoarthritis (OA), 1622–1632.e3 acupuncture for, 1630, botanical medicines for, 1629, considerations for, 1622–1623, 1623f conventional pharmacological treatment for, diagnosis of, 1622, diet and supplements for, 1625, dietary guidelines for, 1625–1630 environmental toxins and, exercise for, 1625, 1631–1632 glucosamine for, 630–632, 632t joint diseases, 1622t magnetic therapies for, misdiagnosis of, 1624b multifactorial etiology of, 1623b nonpharmacological approaches to pain in, 1625b nutritional supplements for, 1625–1629 pain in, 1623b, 1625b physical therapy for, 1624–1625, 1631–1632 procyanidolic oligomers (procyanidins) for, 828, proteolytic enzymes for, relaxation techniques for, S-adenosylhomocysteine (SAMe) for, 842–843 therapeutic considerations/approaches for, 1624–1625, 1631–1632, 1631f topical analgesics for, 1629–1630 topical application for, Osteocalcin, Osteodentin, Osteopathic College (Michigan State), Osteopathy, 40–41 Osteoporosis, 1633–1658.e17 bisphosphonates for, 1645–1646 boron for, commonly prescribed drugs for, 1640–1643, 1645t comorbidities of, considerations for, definition of, dehydroepiandrosterone for, diagnosis of, 1633–1635 Bindex, biochemical markers of bone turnover, 1634–1635 dual-energy X-ray absorptiometry, fracture risk algorithms, diet and supplements for, 1657–1658 environmental toxins of, 1643–1645 cadmium, 1643–1644 excessive alcohol consumption, fluoride, lead, mercury, pesticides, 1644–1645 exercise for, genetic susceptibility for,

# I-36INDEX

Osteoporosis (Continued) hormone replacement therapy for, lifestyle factors for, menopause and, minerals for, 1647–1653 boron, calcium, 1647, 1648f–1649f copper, iodine, 1651–1652 magnesium, 1647–1648 manganese, selenium, silicon, 1650–1651 strontium citrate, 1652–1653 zinc, 1648–1650 nutrient insufficiencies of, 1645, 1645t nutritional supplements for, over-the-counter drugs for, 1640–1643 antacids, anticoagulants, anticonvulsants, antidepressants, aromatase inhibitors, benzodiazepines, calcineurin inhibitors, glucocorticoid medications, 1641, 1642f gonadotropin-releasing hormone agonists, H2 blockers, hormonal contraceptives, 1642–1643 insulin-sensitizing medications, loop diuretics, 1641–1642 opioid pain medications, proton pump inhibitors, thyroid hormone replacement medications, pathophysiology of, 1633–1634 pharmacological therapy for, 1645–1647 adverse effects of, 1645–1647, 1646t prevalence of, 1635–1638 prevention and reversal for, risk factors of, 1635–1638 bone formation, bone resorption, conditions, diseases, and medications, endocrine disorders, environmental factors, ethnicity, gastrointestinal disorders, genetic diseases, hematological disorders, hypogonadal states, inflammation, lifestyle factors, medications, for men, need for DXA screening, 1635–1636 neurological and musculoskeletal, nonalcoholic fatty liver disease, nutritional factors, rheumatic and autoimmune diseases, single-nucleotide polymorphisms, vitamin D deficiency, 1635–1636 secondary causes of, 1638–1645 therapeutic considerations/approaches for, 1645–1658 vitamin K for, 926–937, 926f vitamins for, 1653–1657 B vitamins, omega-3 essential fatty acids, 1656–1657 vitamin A, 1654–1655 vitamin C, 1655–1656 vitamin D, vitamin E, vitamins K 1 and K 2 , 1653–1654 Other Healers, Other Cures (Kruger), 36, 40, Otitis externa, Otitis media, 1659–1665.e2, 786, 1660f botanical medicines for, causes/risk factors of, 1660–1661, 1661f description of, diagnosis of, diet for, Echinacea for, homeopathy for, humidifiers for, naturopathic ear drops for, 1663, nutritional supplements for, 1664–1665 Otitis media (Continued) osteopathic manipulation for, physical medicine for, probiotics for, Sinupret for, standard medical treatment for, 1659–1660 therapeutic considerations of, 1661–1664 bottle-feeding, food allergies, 1662, 1662t gastrointestinal reflux, thymus gland extract for, vitamin A for, vitamin D for, xylitol for, Ototoxicity, Out-of-specification (OOS) studies, 722, Ovarian cancer, Viscum album for, Ovarian dysfunction, in PCOS, Ovarian function, Ovarian reserve, Over-the-counter medicines, Overactive bladder (OAB), 1253, 1533, 1534f causes/contributing factors of, Oxalates, 1178, 1520t, 1523b–1524b Oxidation, of fatty acids, Oxidative stress, aging, and chronic disease, 733–735 antioxidants for, 741, 747–748 and cell signaling cascades, 734–735 chronic, 18b endometriosis and, exercise and, 748–749 female infertility and, Ginkgo biloba extract for, 745–746 grape seed extract for, laboratory assessment of, 735–736 in Parkinson’s disease, 1667–1668 in PCOS, quercetin for, sarcopenia, 1785, and toxicant exposure, transcription factors, Oxihumate, OXM. See Oxyntomodulin 5-Oxoproline (pyroglutamate), OXTR. See Oxytocin receptor Oxygen delivery, smooth muscle constriction, Oxygen free radicals, Oxyntomodulin (OXM), Oxytocin, Oxytocin receptor (OXTR), Ozone, asthma and,

# P

PA. See Phosphatidic acid Pacific College of Naturopathic Medicine, PAD. See Peripheral artery disease Paeonia lactiflora (white peony), 1450–1451 for PCOS, 1704–1705 PAG Advisory Committee, PAHs. See Polyaromatic hydrocarbons Pain (dolor), breast, fibrocystic breast disease (FBD) and, Cannabis for, Pain distribution body form, 1325, 1326f–1328f Pain/pain management acceptance as factor in pain management, analgesic agents adverse effects of, 1711b topical analgesics, 1629–1631 analgesic rebound headache, 1577–1578 attention focusing, 341–342 centralization of pain test, cognitive strategies, counterstimulus methods, 342–345 Croton lechleri, 548–549 end-range pain (ERP), Epilobium species, experience of, 339–341 Fibromyalgia Impact Questionnaire (FIQ), FibroQuest symptoms survey, gate control theory, hypnosis or autohypnosis, Pain/pain management (Continued) with inflammatory disorders, 333–334 massage/biofeedback/nutritional/botanical, mean pressure/pain threshold, Mentha piperita (peppermint) for, mouth pain, night pain, nonpharmacologic, 339–345.e3 Opuntia species (prickly pear) for, in osteoarthritis, 1623b, 1625b pain distribution body form, 1325, 1326f–1328f pain during motion, Pediatric Pain Program, peripheralization of pain test, Piper methysticum (kava), placebo, postherpetic neuralgia, postmastectomy pain, psychological strategies, relaxation training, transcutaneous electrical nerve stimulation, 342–343, 343t Zung’s self-rating depression scale, Painful bladder syndrome. See Cystitis/interstitial cystitis/ painful bladder syndrome Pakriti, Paleolithic diet, Palliation, 83b Palmer, B. J., 36, Palmer, Daniel David, 31, Palmer School of Chiropractic, 41–42 Palmitic acid, Palmitoleic acid (PA), Palpation techniques, Panax ginseng (Korean ginseng), 756–767.e4, adaptogenic and antistress activity, 757–760 for anticancer properties, 763–764, 763f for antidepressant and anxiolytic effects, for antifatigue activity, 759–760 for antiobesity, 765–766, 766f for cardiovascular effects, 764–765, 764f for cell proliferation, antioxidant, and antiaging effects, for central nervous system effects, 766, 766f chemical composition of, 756–757, 758f for cognitive performance, 760–761 common names of, description of, 756, 757f for diabetes management, 761–762, dosage of, drug interactions of, for ergogenic effects, extract, for hepatic effects, history and folk use of, 757, 759b for immunomodulating effects, 762–763 indications for, 759b for male infertility, 1470, for menopause, 762, pharmacology and clinical indications of, 757–766, 759f for radiation protection, for reproductive effects, toxicology of, 766–767 Panax quinquefolium, Pancarcinoma-associated antigen, Pancreas cancer of, 354, digestive physiology, diseases of, Pancreatic cancer, Viscum album for, Pancreatic enzymes, 768–776.e4, 113, 228, 230t, 1211–1212 absorption of dietary proteins, of enzymes, 769–770 amylase, 771b for autoimmune and immune complex-mediated diseases, benefits of/future uses of, for cancer, for cardiovascular disorders, chymotrypsin, 771b clinical applications of, 771–772 description of,

# I-37INDEX

Pancreatic enzymes (Continued) for digestive disorders, dosage of, drug interactions of, 775–776 enzyme combinations, 772b factors affecting activity of, cofactors, inhibitors, metal ions, pH range, substrate concentration, supplement coating, temperature, history of clinical use of, 768–769 for inflammatory conditions, 772–773 lipase, 772b measuring activity of, for multiple sclerosis, pancreatic elastase 1, 229–230, 230t, 235b pancreatin, 772b for rheumatoid arthritis (RA) treatment, standardization of, supplements commonly used, 769–776 toxicology of, oral enzymes, in treatment of chronic candidiasis, trypsin, 771b secretion, for uterine fibroids, for viral and bacterial disorders, 774–775 Pancreatic extracts, in glandular therapy, 303–304, 303t Pancreatic insufficiency, 717, 983–984 Pancreatin, 772b Paneth cells, Panic disorder, 5-hydroxytryptophan (5-HTP) for, Pantetheine, 991f Pantethine, 991f, 1110, Pantothenic acid, 991f, for osteoarthritis, 1627, for rheumatoid arthritis, status determination of, Pap smears, Papillomavirus, Papulopustular rosacea, Para-aminobenzoic acid, for dermatitis herpetiformis, Paracellular pathway, Paracelsian medical systems, Paracelsus, Paraquat, Parasitic infections, 235b antiparasitic botanicals, gastrointestinal, of infectious diarrhea, vitamin A for, Parasympathetic nervous system, Parathyroid hormone (PTH), Parkinson’s disease (PD), 1666–1674.e3, acupuncture and tui na for, 1672–1673 botanical medicines for, citicoline (CDP-choline) for, 519–520 coenzyme Q 10 for, conventional medicine for, 1669–1671 depression in, 667t diagnosis of, 1666, 1669, diet for, dietary recommendations for, epidemiology of, 1666–1667 estrogen modulation for, exercise for, homeopathy for, lifestyle recommendations for, pathophysiology of, 1667–1668, 1667f environmental exposures, 1668–1669 mitochondrial dysfunction and inflammation, oxidative stress and glutathione deficiency, 1667–1668 substantia nigra cell death, risk/benefit of smoking and, supplements for, therapeutic considerations/approaches for, 1669–1673 Partial (focal, local) seizures, 1297b Particulate matter Alzheimer’s disease and, asthma and, atherosclerosis and, 1135, 1136f Passiflora (passionflower), Passiflora incarnata, clinical applications, insomnia, 1492 Passive movement tests, range of motion, Past symptoms, 1018t–1019t Pasteur, Louis, Patchouli essential oil (Pogostemon cablin), 1860, 1861f Pathobiography, 20b Pathogenic agent, Pathogenic microorganisms, antagonism against, Pathology, in naturopathic model specific pharmacologic or synthetic substances, use of, specific substances, modalities, interventions, use of, 23–24 suppressing, 17b, Pathya (diet), Patient self-responsibility, Patrick’s test, Pattreiouex, Allen, Pau d’arco, 868–872.e2 Pauling, Linus, PBLs. See Peripheral blood lymphocytes PCBs. See Polychlorinated biphenyls PCOS. See Polycystic ovary syndrome PCR testing, PD. See Parkinson’s disease Peat therapeutics, 372–374 for ankle sprains, for ankylosing spondylitis, for arthritis, conditions indicated for, for dermatologic problems, for discopathy, for hamstring strain, for headache, for hematoma, for herpes virus, 374–375 history of, 372–373 for human papillomavirus, hyperthermia with, 373–374 for immune stimulation, indications/contraindications, 376b, 378b for infertility, medicinal peat bath, 375–377, 378b medicinal peat peloid, 377–378 for myopathy, physiological effects of, for scleroderma, for scoliosis, skin response to, Pediatric intoxication, Pediatric Pain Program, Pelargonium sidoides (South African geranium) bacterial sinusitis, for bacterial sinusitis, pneumonia and bronchitis, 1198–1199, 1199f, in streptococcal pharyngitis, Peloid therapy, 377b about, indications/contraindications, 377b Pelvic floor muscle, for overactive bladder, Pelvic inflammatory disease (PID), 1675–1682.e2 antibiotics for, botanical medicines for, 1680–1681 CDC recommendations for, 1679b complications of, 1676–1677 description of, diagnosis of, 1675, 1678, 1678t diathermy for, 1680, differential diagnosis of, 1678b education for, etiology of, 1675–1676, 1676t anaerobic organisms, Chlamydia trachomatis, facultative aerobic organisms, Neisseria gonorrhoeae, incidence of, 1675–1676 nutritional supplements for, oral treatment for, pathogen access, prevention of, 1680–1681 risk factors for, sitz baths for, 1680, Pelvic muscle rehabilitation, for overactive bladder, Pelvic torsion (Gaenslen’s) test, Penicillin, allergenicity of, 1825–1826 Penicillium, Pentosan polysulfate sodium (Elmiron), Peppermint, 1224–1225 for gallstone treatment, for irritable bowel syndrome, 1503t–1504t Pepsin A, 154, Pepsinogen, Peptic ulcer disease, 1683–1688.e2, 231, 349–350, 1684f botanical medicines for, description of, diagnosis of, diet for, etiology of aspirin/nonsteroidal antiinflammatory drugs, food allergy, Helicobacter pylori, 1683–1685 gastric ulcers, H. pylori, lifestyle factors of, psychological considerations for, stress and emotions, supplements for, therapeutic considerations/approaches for, Peptic ulcers glutamine for, water intake and, Peptide YY (PYY), Peptides anti-ACE, ghrelin, orexin A, peptide YY, receptor sites, Peptostreptococcus, Perchlorate, 218t–219t, exposure, 1722, 1723t–1724t Perfluorochemical exposure, in pregnancy, 1723t–1724t Perfluorooctane sulfonate, attention deficit hyperactivity disorder (ADHD) and, Performance enhancement, boron and, flavonoids for, 616–617 Performance nutrition, recovery and nutrient timing, Perianal dermatologic disorders, 1753–1755 botanical medicines for, condylomata acuminata, condylomata lata (anogenital warts), herpes simplex virus, lymphogranuloma venereum, pilonidal sinus tract, 1753–1754 proctalgia fugax, proctitis, pruritus ani, 1754–1755 treatment options for, Perimenopausal women, insomnia in, melatonin for, Perimenopause, 1567–1568 depression in, melatonin for, 703–704 Periodontal disease, 1689–1693.e1, 1690f AB blood group and, botanical medicines for, description of, diagnosis of, hygiene for, pathological process of ABO blood groups and, pathophysiology of, 1689–1691 amalgam restorations, 1690–1691 bacterial factors, complement system, environmental toxicants, gingival sulcus, 1689–1690 local factors, lymphocytes, macrophages and monocytes, mast cells and immunoglobulin E, polymorphonuclear leukocytes, tobacco and alcohol, prevalence and epidemiology of, therapeutic considerations/approaches for, 1691–1693 Peripheral artery disease (PAD), Peripheral blood lymphocytes (PBLs), 119–120, 119f Peripheral nervous system, Peripheral vascular disease (PVD),

# I-38INDEX

Peristalsis, 113–114 Permanence, Permethrin, Pernicious anemia, nutritional support for, 1106–1107 Peroxidase family, as antioxidants, 736–737 glutathione peroxidases, 736–737 Peroxynitrite, Persistent organic pollutants (POPs), 733, 1269, 1269f, 1602 kidney disease and, Personal Health Inventory (PHI), Personal history, endometriosis and, 1287–1288 Personality explanatory style, immune function and, Personalization, Peruvian bark (Cinchona officinalis), 307–308 Pervasiveness, Pessimistic explanatory style, Pesticide neurotoxicity, 275–276 Pesticides Alzheimer’s disease and, exposure, in pregnancy, 1723t–1724t food crops, 365–366 rotenone, Petasites hybridus (butterbur), 1584, PFFAs. See Plasma free fatty acids PGX. See PolyGlycoPlex pH of stomach, of urine, 1520t Phage therapy, 777–787.e3, 782f advantages/potential of, clinical application of, 783–786 clinical research of, 783–784 description of, dosing strategy of, drug interactions of, for ear infections, for gastrointestinal infections, historical context of, 780–781 commercialization, discovery and research, early problems with, Western explorations, phage interactions in body, 781–783 properties of bacteriophages, 778–780, 778f for respiratory tract infections, for Staphylococcus aureus infections (MRSA/nonMR- SA), 784–785 toxicology of, types of, 779f for urogenital tract infections, Phalen’s sign, Pharmaceutical industry growth of, 267–268 history of U.S, patents for plants, Pharmacology, of Melaleuca alternifolia (tea tree), Phellinus igniarius, 689, 689f Phellinus linteus, Phenibut, Phenolic compounds, 680, 681f Phenolic metabolites, Phenolics, Phenylacetic acid, Phenylalanine, 1073, 1074t metabolites, PHI. See Personal Health Inventory Philosophy of naturopathic medicine, 12–13, Phlebectomy, Phlegm, 398t Phlegmatic temperament, 398t Phosphate additives, osteoporosis and, Phosphates, kidney disease and, Phosphatidic acid (PA), Phosphatidylcholine (lecithin), 989f, 992–993, metabolism, 989f Phosphatidylcholine-bound silybin, Phosphatidylserine (PS), 788–790.e1 chemical structure of, 789f clinical applications of, 789–790 description of, dosage of, drug interactions of, Phosphatidylserine (PS) (Continued) evolution of, 789–790 for memory decline, pharmacology of, 788–789 physiological roles of, for stress, toxicology of, Phosphorus, 197, Photoprotection, Photosensitivity, Hypericum perforatum (St. John’s wort) and, Photosensitivity disorders, Phototherapy, for urticaria (hives), 1830, Phrenological Journal, Phthalate exposure, 1722, 1723t–1724t Phthalates, 1270, for menopause, 1559–1560 Phyllanthus amarus, 1365, 1388b Phyllanthus niruri, Phymatous rosacea, “Physcultopathy”, Physical activity in pregnancy, 1718–1719 for sarcopenia, 1786, Physical barrier, intestinal, 167–169 adherens junctions, desmosomes, gap junctions, intercellular junctional complexes, 168, 168f intestinal epithelial cells, 167–168 mucosal layer, tight junctions, 168–169 “Physical culture” school of health and healing, Physical examination, in fibromyalgia syndrome, Physical inactivity, atherosclerosis and, Physical medicine for carpal tunnel syndrome, 1204–1205 for HIV/AIDS, 1388–1389 for irritable bowel syndrome, Physical therapy, for overactive bladder, 1540, 1544, 1544b Physicians “botanics” (professional Thomsonian doctors), drugless, mission of, national directory of drugless, naturopathic, teachings of, Physician’s Health Study, Physiological processes, functional medicine model of, Physiology, Ayurvedic, functions of Tridosha, properties of Dosha, psychosomatic constitutions, Physiotherapy, for overactive bladder, Phytic acid (inositol hexaphosphate), Phytochemical antioxidants, 735, anticancer, 367t curcumin, Ginkgo biloba extract, 745–746 metabolism of, resveratrol, 746–747 silymarin, Phytoestrogens bioavailability of, effects, of Angelica species, herbal, 1837–1838 sources of, 1561t Phytolacca, for chronic kidney disease, Phytolacca americana (poke root), Phytopharmaceuticals, Phytostanols, for lowering cholesterol levels, Phytosterols, for lowering cholesterol levels, Phytotherapy, 403t PID. See Pelvic inflammatory disease Pills (Vati, Goti, Modak), 261–262 Pilonidal sinus tract, 1753–1754 Pima Indians, Pine bark (Pycnogenol) for endometriosis, extract of, atherosclerosis and, for glaucoma, Pine bark extract (Pinus pinaster), for gout, Pineapple, Píng gū, 685–686, 685f Pinus maritima (or pinaster) (pine bark), for cataracts, for hemorrhoids, for inflammatory bowel disease, Piper methysticum (kava kava), 791–796.e1, 792f, analgesic effects, anti-inflammatory effects, anti-ischemia effects, anxiolytic effects, ceremony, chemical composition, 791, 792f kavalactones, 792t clinical applications, 794–795 description, dosage, drug interactions, effects of drinking, for hepatitis viruses, history and folk use, 791–793 kavalactones compared with crude extracts, 793–794 for menopause, for Parkinson’s disease, pharmacology, 793–794 sedative effects, side effects and toxicity, 795–796 Piper rotundum (black pepper), Piscidia piscipula (Jamaican dogwood), Pistacia lentiscus, for gastroesophageal reflux disease, Pit constitutional type, Pit Dosha, Pizzorno, Joseph E., Placebo/placebo response, for altered states of consciousness, 99–101 art of medicine in using, clinical application of, 95–101 clinical observations, 89–90 conditioned responses and, 98–99 conditions shown to respond to, 91b “conscious” placebo, description of, for enhancement of positive emotional states, 96–97 ethics of, healing mechanisms of, 92–94 conscious control over homeostasis, 92–93 neurophysiology, physiological and psychological stress, stress physiology, 93–94 history of, 5-hydroxytryptophan (5-HTP) versus, 667t interactions, 91–92 myths about, 90–91 optimizing response to, 95b origin of term, packaging and delivery modes, pharmacodynamics of, 91–92 physiological changes induced by, 91t placebo sag, for prima non nocerum, Pygeum africanum versus, 831t reason for studying, 88–89 for support of therapeutic relationship, symptoms and side effects of, 90b for therapeutic conditioning or learning, 98–99 for tollem causum, 95–96 types of, 89b Plague, immunity to, Planes, astral and mental, Plant sterols, for lowering cholesterol levels, Plasma free fatty acids (PFFAs), elevated levels of, Platelet aggregation inhibition, Allium sativum (garlic) for, Platelets aggregation of, 1144–1145 effects of Zingiber officinale (ginger) on, 966–967 migraine headaches and, 1576–1577 Pleiotropism, Pleurotus ostreatus (Hiratake, píng gū), 685–686, 685f PMS. See Premenstrual syndrome Pneumata, Pneumatology, Pneumonia, 1196–1201.e1 bottle blowing and salt pipes for, 1200–1201 diagnostic summary for, 1197–1198

# I-39INDEX

Pneumonia (Continued) etiology, 1197t expectorants for, 1198, mucolytics for, mycoplasmal pneumonia, pneumococcal pneumonia, recommendations for, therapeutic considerations for, 1198–1200 viral pneumonia, Pneumus boldo, for gallstone treatment, Podophyllium resin, 1388b Points (acupuncture), Poke root (Phytolacca americana), Poke root oil, 1837, Polish Academy of Sciences, 783–784 Pollutants organic, atherosclerosis and, persistent organic pollutants, 1269, 1269f type 2 diabetes and, Polyamines, 1760f Polyantigenic organisms, Polyaromatic hydrocarbons (PAHs), Polybrominated diphenyl ethers attention deficit hyperactivity disorder (ADHD) and, 1158 exposure, in pregnancy, 1723t–1724t Polybrominated flame retardants, Polychlorinated biphenyls (PCBs), 272, 726, atherosclerosis and, exposure, in pregnancy, 1723t–1724t in infertility, for menopause, Polycystic ovary syndrome (PCOS), 1694–1706.e7 advanced glycation end-products for, 1699–1700 alpha-lipoic acid for, antioxidants for, B vitamins for, 1700–1701 botanical medicines for, 1704, caffeine for, carnitine for, causes of, adrenal dysfunction, androgen excess/hyperandrogenism, attenuated apoptosis, chronic low-grade inflammation, 1695–1696 environmental toxins, genetic determinants, insulin resistance and insulin action abnormalities, 1695 neuroendocrinology dysfunction of hypothalam- ic-pituitary axis, obesity, ovarian dysfunction, oxidative stress, prenatal androgen exposure, chromium for, classification of features, description of, diagnosis of, 1694, 1695t, 1697, 1698t recognized phenotypes, 1697, 1698t signs and symptoms, dietary considerations for, 1697–1699, Dietary Approaches to Stop Hypertension diet, low-GI diet for, Mediterranean diet for, essential fatty acids for, exercise for, flavonoids for, inositol for, lifestyle measures for, 1705–1706 magnesium for, Maitake for, nutritional supplements for, 1700–1703, probiotics for, refined carbohydrates for, saturated fats and deep-fried foods for, selenium for, stress management for, 1705–1706 sugar for, therapeutic considerations for, 1697–1705 vitamin D for, 1702–1703 vitamin E for, weight loss for, weight management for, zinc for, Polyerga, glandular therapy for, 303t, 304–305 PolyGlycoPlex (PGX), 978, Polymorphism, reasons for existence of, Polyols, Polyphenols, 742, gastrointestinal tract as primary target for, for peptic ulcer disease, Polysaccharides, 679–680, 680f Polyunsaturated fats, osteoporosis and, Polyunsaturated fatty acids, Pomegranate (Punica granatum), for atherosclerosis, Pomegranate extract, Pomegranate flower, POPs. See Persistent organic pollutants Porphyrias, 1707–1713.e1, 1711b acute intermittent porphyria, antioxidants for, B-complex vitamins for, biochemistry of, 1707–1708 heme formation, 1708, 1708f–1709f carotenoids for, classifications of, considerations for, 1710–1713 constitutional hydrotherapy for, description of, detoxification of liver and colon for, diagnosis of, 1707, 1709–1710 diet for, 1711–1713 etiological agents of, known drugs, 1711b toxins, 1711b iron supplementation for, laboratory diagnosis of, 1709–1710 manifestation of, 1708–1709 ozone therapy for, primary, 1708b signs and symptoms of, supplements for, therapeutic approach for, types of, urinary porphyrins, 246t Porphyrinogens, Positional release methods, 384t Positive mental attitude, 102–105.e1 cardiovascular health and, chronic fatigue syndrome and, immune function and, 102–103 learned optimism, 104–105 longevity and, Maslow’s Hierarchy of Needs, 103, 103f, 104t self-actualization and, 103–104 Positive pregnancy, Post-Avicennan medicine, 394–395 Posterior shear (thigh thrust) test, Postherpetic neuralgia, Postmastectomy pain, Postmenopausal women, BMI, melatonin, fluoxetine and, Postmenopause, procyanidolic oligomers (procyanidins) for, Postmucosal factors, in excretion of sugar probes, Postpartum obesity, probiotics and, 818–819 Posttraumatic stress disorder, Cannabis for, Posture, 335, overactive bladder and, Postwar scholarship more curriculum and, new development in, 57–58 Potassium, 197–198, 368–369, 1053, 1394–1395, atherosclerosis and, hair mineral analysis for, Potassium iodide, for erythema multiforme (EM), 1308–1309 Potentilla tormentilla (tormentil root), 1428, Potentized remedy, Poultry, ASD and, Povidone-iodine, Powders (Churna), 261–262 PPIs. See Proton-pump inhibitors PQQ. See Pyrroloquinoline quinone Prakriti, 257, Pranayama, Prayer, as breathing rehabilitation exercise, 1007b Prebiotics, 797–808.e4 chemical structures of, 799f concept, 798f Prebiotics (Continued) for constipation, defined, fiber, for inflammatory bowel disease, 1484–1487 mushrooms as, and target organisms, 800t Preconception, 1714–1738.e8, Prediabetes (impaired glucose tolerance), Predigestion method, in glandular preparations, Pregnancy, 1714–1738.e8 alcohol intake in, arsenic exposure in, Cannabis and, 481–482 cannabis exposure in, cocoa intake in, death rates and premature births, dietary supplements in, 1725–1738 antioxidants, 1736–1737 biotin, 1725–1730 calcium, carnitine, carotenoids, 1730–1731 choline, 1731–1732, 1732t folate, 1732–1733 iodine, 1733–1734 iron, magnesium, 1734–1735 multivitamin, 1725, 1726t–1729t omega-3 fatty acids, 1735–1736 vitamin A, vitamin C, 1736–1737 vitamin D, 1737–1738 vitamin E, 1736–1737 zinc, energy needs and diet, exercise during, 1718–1719 healthy foods, environmental toxin exposure in, 1722–1724, 1723t–1724t ephedra and, fasting during, fish oil intake for, healthy weight for, 1717–1718, 1718t hydration/fluid intake, hydrotherapy guidelines for, 321–322 Hypericum perforatum (St. John’s wort) and, 675–676 lifestyle factors in, 1717–1725 miscarriages, 1436t, 1440–1441 nutrition for, 1716–1717 obesity and, preconception and, 1715–1716 risk factors for, saunas during, sleep during, 1719–1720 smoking during, 1721–1722 stress and mind-body modalities for, 1724–1725 substance use in, 1720–1724 treatment of stretch marks, use of Commiphora mukul in, weight gain in, 1718t Preissnitz, Vincent, Premenstrual syndrome (PMS), 1739–1747.e3, 627, 956–958, 957t, bioidentical progesterone therapy for, botanical medicines for, 1744–1747 classification, diagnosis, dietary considerations, 1741–1742 estrogen metabolism, 1740–1741 exercise for, general considerations, 1739–1740, 1740b hypoglycemia and, L-tryptophan for, Melissa officinalis (lemon balm) for, nutritional supplements, 1742–1744, stress, coping style, depression and, 1742, 1742b therapeutic approach, 1746–1747 therapeutic considerations, 1740–1746 thyroid function and, vitamin B 6 for, Premucosal factors, in excretion of sugar probes, Prenatal androgen exposure, in PCOS, Presarcopenia, “Preventive genomics”,

# I-40INDEX

Preventive medicine, 81b Allium sativum (garlic) uses, for cancer, 447–449 genomic testing for, 148–149 hepatitis viruses, 1359–1360, 1359b Price, Weston A., Prickly ash (Xanthoxylum americanum), Priessnitz, Vincent, Prima non nocerum, 95b Primary headache, melatonin for, Primary insomnia, magnesium, melatonin, and zinc for, 698–699 Primary pancreatic exocrine insufficiency, Primer for Exercise and Nutritional Sciences (Scott), Principles and Practice of Drugless Therapeutics, Principles of living, Principles of Manual Medicine (Greenman), Proanthocyanidin B2, 544f Proanthocyanidins, 742–743 Probiotic supplements, Probiotics, 809–822.e5, 175, 176t affective disorders, 1071–1072 for asthma, for atopic dermatitis (eczema), characteristics, 811–812, 811t importance of strain, nomenclature, 811–812 in use, 811, 811t clinical applications, 813–816 abdominal pain (functional), antibiotic use, 813, 814t atopic eczema, 813–814 colon cancer, constipation, Crohn’s disease, gastrointestinal infections, 814–816 immune enhancement, 816–820, 817t infantile colic, inflammatory bowel disease, irritable bowel syndrome, 816–817, 818t mastitis, nonalcoholic fatty liver disease, postpartum obesity, 818–819 toxin reduction, ulcerative colitis, 817–818, 819t urogenital infections, 819–820 commercial forms, 812–813 for constipation, for Crohn’s disease, 1486t definition, description, 809–810 dosage, in dairy mediums, supplements, drug interactions, for female infertility, for hepatitis viruses, for HIV/AIDS, for infectious diarrhea, for inflammatory bowel disease, 1486, 1486t for irritable bowel syndrome, 1499, 1501f–1503f for male infertility, for oral thrush, for PCOS, for pelvic inflammatory disease, for peptic ulcer disease, 1687–1688 proposed mechanisms of action, 810–811 antagonism against pathogenic microorganisms and viruses, anti-inflammatory activity, beneficial compounds production, 810–811 competition for GI adhesion sites, decrease visceral hypersensitivity, GIT transit time modification, immune modulation, induction of oral tolerance, selective GI antimicrobial activity, strengthen the intestinal barrier, pros and cons of, 812t for rheumatoid arthritis (RA) treatment, for small intestine bacterial overgrowth, for streptococcal pharyngitis (strep throat), toxicity, 821–822 for treatment of candidiasis, for urticaria (hives), “Process of Healing, a Unifying Theory of Naturopathic Medicine”, Procollagen type III N-terminal peptide, Proctalgia fugax, Proctitis, Proctologic conditions, 1748–1756.e1 anal cryptitis, anal fissures, anal fistula and anal abscesses, 1748–1749 anorectal anatomy, botanical medicines, for hemorrhoids, hemorrhoids, 1750–1752 perianal dermatologic disorders, 1753–1755 botanical medicines for, condylomata acuminata, condylomata lata (anogenital warts), herpes simplex virus, lymphogranuloma venereum, pilonidal sinus tract, 1753–1754 proctalgia fugax, proctitis, pruritus ani, 1754–1755 treatment options for, treatment, Procyanidolic oligomers (procyanidins), 823–828.e2, 745 anticancer activity, 824–825 antiinflammatory activity, antioxidant and free-radical-scavenging activity, 823–824, 824b for antioxidant therapy, 825–826 for asthma, for atherosclerosis, hypertension, metabolic syndrome, type 2 diabetes, 826–827 for attention deficit disorder, for attention deficit hyperactivity disorder, cardiovascular protection, 825, 825f chemical composition, 823, 824f clinical applications, 825–828 collagen protection, description, dosage, drug interactions, for hemorrhoids, history and folk use, for male infertility, for menopause and postmenopause, for mild cognitive impairment, for osteoarthritis, 1629, for periodontal disease, pharmacology, 823–825, 824b for psoriasis, toxicity, for venous insufficiency and capillary fragility, for visual function, retinopathy, and macular degen- eration, Profession, evolution of, in pacific northwest, 53–54 Professional medicine in early America, 26–27 need for standards in, Progesterone, 1068, asthma and, bioidentical, cream, schedule, for endometriosis, 1295t melatonin with, for menopause, for menorrhagia, Progressive relaxation, for insomnia, Proinflammatory cytokines, Proinflammatory eicosanoids, Prolyl endopeptidase, Propolis, clinical applications of, Propranolol, coenzyme Q 10 and, 535–536 Proprietary topical therapy, Propylene oxide, 218t–219t Prostaglandins, Prostate benign prostate hypertrophy, Pygeum africanum versus Serenoa repens, urinary tract infections and, Prostate cancer boron for, 455–456 carotenoids for, Prostate cancer (Continued) lycopene in, 448–449 soy intake and, Protease inhibitors, Proteases, Protein in chemically induced illnesses, excessive, osteoporosis and, 1638–1639 metabolism of, in pregnancy, recommended daily allowance for, Protein compounds malabsorption of, storage and transport of, Protein kinases, 734–735 Protein phosphatases, 734–735 Protein powders, Protein sparing, 635–636 Proteinemias, Proteoglycans, sulfated, Proteomics, for mold exposure assessment, Prothrombin, in fertility assessment, 1459t Proton-pump inhibitors (PPIs), for osteoporosis, Protozoan infections, intestinal diagnostic considerations, therapeutic considerations, Protozoan infestation, intestinal, Entamoeba histolytica, 1493–1494 Giardia spp, 1493, 1494f Provocation-neutralization testing, Provocation tests, metal retention, 190–191 Prunella vulgaris, 1388b Pruritus ani, 489, 1754–1755 PS. See Phosphatidylserine Pseudoephedrine, Pseudohyperkalemia, Pseudomonas aeruginosa, Psilocybe spp., 690, 690f Psora (itch), Psoriasis, 1757–1766.e3, 489, advanced glycation end products, Aloe vera (Cape aloe) for, botanical medicines for, celiac disease and, 1758–1759 Chaga for, Coleus forskohlii for, depression and, diagnosis, diet, fasting, and food allergy control for, 1761, 1766 environmental toxins, fish oils for, 603–604 fumaric acid for, gastrointestinal comorbidities and, general considerations, 1757–1759, 1758f Glycyrrhiza glabra (licorice) for, homocysteine and DNA methylation, individual nutrients for, 1761–1762 inflammatory bowel disease and, inflammatory leukotrienes, neuropeptides and skin microbiome, 1757–1758 nonalcoholic fatty liver disease and, nutrition for, 1761–1762 pathogenesis, physical therapeutics of, 1762–1763 psychological aspects of, scalp, 1763, 1765f stem cell therapy for, sunlight, ultraviolet light, climatotherapy, and balneo- therapy for, 1762–1763 therapeutic approach, botanical medicines, diet, physical medicines, psychological considerations, supplements, topical treatment, therapeutic considerations, 1760–1766 bile deficiencies, 1760–1761 bowel toxemia, incomplete protein digestion, liver function, topical treatments for, 1763–1766, 1764f–1765f Psychological aspects, urticaria (hives) and,

# I-41INDEX

Psychological issues in Ayurvedic medicine, desire to be healthy, emotional mediators of illness, 6b as health determinants, 19b of HIV/AIDS, 1386–1387 Maslow’s Hierarchy of Needs, in obesity, 1609–1610 panic disorder, of psoriasis, stress effects, support for acne treatment, Psychology hyperventilation syndrome/breathing pattern disor- ders and, 1001–1002 positive clinical, Psychoneuroimmune system, Psychosis, Cannabis and, Psychosomatic constitutions (prakriti), 259, 260t, 260b Psychosomatic phenomena, Psyllium, 980, PTH. See Parathyroid hormone Public and community health concerns, 19b Pueraria lobata (Kudzu), Pueraria mirifica (kudzu), Pulse, Unani medicine in, 400–401, 401f Pumpkin seed (Cucurbita pepo), for overactive bladder, 1541 Purine synthesis, 1350f Purkinje shift, Pursed lip breathing exercise, 1007b Purslane, for lichen planus, Purusha, Putrefactive short-chain fatty acids, PVD. See Peripheral vascular disease Pygeum africanum (bitter almond), 829–832.e1 for benign prostatic hyperplasia, chemical composition, 829, 829f clinical applications, 830–832 components of, description, dosage, drug interactions, ferulic acid esters, history and folk use, 829–830 for male infertility, 1470, and impotence, pharmacology, for prostate disorders, 830–831 Serenoa repens versus, studies on use of, 831t toxicology, Pyophagine, Pyrethroids, 218t–219t Pyridoxal 5´-phosphate (P5P), 990, 990f Pyridoxine, status determination of, Pyroglutamate (5-oxoproline), 243–244 Pyrroloquinoline quinone (PQQ) chemical composition, clinical applications, 834–835 enhancing cognitive function, 834–835 insulin resistance, description, dosage, drug interactions, history and folk use, pharmacology, 833–834 structure, 833f toxicity, Pyruvic acid, Pyuria,

# Q

Qi, Qigong, 23, Q-SYMBIO trial, Quacks/quackery, Quality of life, 82, Quality questionnaire, Quercetin, 614–615, 746, 871–872, aphthous stomatitis and, for cancer, chemical descriptions of, 613–614, 614f commercial forms of, dosages of, Quercetin (Continued) for gout, 1352–1354 for inflammatory bowel disease, 1483–1484, for nonbacterial interstitial cystitis/painful bladder syndrome, for sport nutrition, toxicity, for urinary tract infections, for urticaria (hives), Quercitrin, 582f Questionnaire interpretation, 1022–1025 NMI guidance example, 1022–1024 Quinn, Frederick Harvey Foster, Quinn, Sheila, Quinone xyloidone, Qur’an, 405, 406f, 406b

# R

RA. See Rheumatoid arthritis Racial factors, type 2 diabetes and, Radiation, oxidative stress and, Radiation burns, Aloe vera (Cape aloe) for, 425–426 Radiation exposure, protection from, by Eleutherococcus senticosus, Radiation-protecting effects, of Panax ginseng (Korean ginseng), Radiation protection, Melissa officinalis (lemon balm) for, Radiation therapy, 488, Radioimmunoassay (RIA), 159, Rainbow Assortment of Fruits and Vegetables, 365, 366b Raja mind type, Rajas (movement), Rancidity testing, Range of motion (ROM) tests, Rapid dark adaptation test (RDAT), 225–226.e1 clinical application of, conditions causing abnormal, 225t equipment for, interpretation of, procedure, results of, Rapid screening SARC-F, 1793, 1793t Rapidly progressive glomerulonephritis (RPGN), Rapp, Doris, Rational Hydrotherapy (Kellogg), 37, RAUs. See Recurrent aphthous ulcers Raw material (RM), authenticity of, 724–725 botanicals, 725–726 contaminants on, fish oil and vegetable oil products, nonbotanical, potency of, Raynaud disease, fish oils for, RBCs. See Red blood cells RDAT. See Rapid dark adaptation test Reactive nitrogen species (RNS), Reactive oxygen species (ROS), 732, 732f, 734–735, interactome, Read method, Realized beings (Rishi Kapila), Receptor activator nuclear factor-κB ligand (RANKL)-ac- tivated signaling, Recovery, from alcohol dependence, Rectal disorders, Aloe vera (Cape aloe) for, Recurrent aphthous ulcers (RAUs), Recurrent bladder infections, Recurrent kidney infections, Recurrent respiratory infections (RRIs), Viscum album for, Red belted polypore (Fomitopsis pinicola), 688–689, 688f Red blood cells (RBCs), 196–197, Red clover (Trifolium praetense), 1562–1563 Red root, Red wine, atherosclerosis and, 1138–1139 Redness (rubor), Redox balance aging and, gaso-transmitter systems and, gut microbiome and, minerals and, mitochondrial function and, 750–751 thiols in, Redox cycling, Redox regulation, 734–735, 737–738 Reductionism (mechanism), 80–81 Reed, Louis, Refined carbohydrates in PCOS, stress management and, Refinement (Samskara), Reflexes, 336, Reflexology, hand, Reflux Symptom Index (RSI), Regulation of naturopathic medicine state acupuncture laws, U. S states and Canadian provinces, 46b Regulations dietary supplements, herbal medicines, 264–265 Rehabilitation model, for fibromyalgia syndrome, Reily, Reverend Prior, Reinforcement, positive, Reishi (Ganoderma lucidum, G. applanatum, G. tsugae, Lingzhi), 681–682, 681f Relaxation, 342, 1055, Relaxation agents and techniques, for angina, for migraine headaches, 1584–1586 for osteoarthritis, for pain management, relaxation response, 1051b smooth muscle relaxation, Relaxation therapy, 1584–1586 Religion/religious activity, 386–390.e1, 386f definitions, 386–387 in health care, 387–388 health effect of, research, 388–389 Remedies, Remethylation pathway, of homocysteine, 986–987, 986f Renal disease, fish oils for, 608–609 Renal protective effects, of Cordyceps, Renal stones, etiology, fasting and, Renal system. See Kidneys/renal system Repeated chair stand, for sarcopenia, Repetitive strain injuries (RSIs), “Report on Schools”, “Report to the Utah Legislative Council”, Reproduction, carotenes/carotenoids in, Research/studies Ayurvedic medicine, Bureau of Economic and Business Research38 of the University of Utah, Canadian studies, 46b cancer prevention study group, in fasting, appendicitis, chronic posttraumatic headache, follicular lymphoma, fibromyalgia syndrome, health, 388–389 in homeopathy, 312–315 animal studies/field and laboratory, basic research, 314–315 human clinical trials, human effectiveness studies, modern proving study, Journal of Strength and Conditioning Research, in medicinal mushrooms, 691t–692t modern proving study, National Cooperative Crohn’s Disease Study, 1475–1476 phage therapy, 780, 783–784 Physician’s Health Study, Pygeum africanum (bitter almond), 831t religion/religious activity, 388–389 Serenoa repens (saw palmetto) efficacy, Silybum marianum (milk thistle), Society for Acupuncture Research, 251, soy protein, spiritual practices, 388–389 A Study of the Healing Arts With a Particular Emphasis Upon Naturopathy, Veterans Affairs Normative Aging Study, Resistance factors, 17b Resisted isometric tests, Resolution-phase interaction products, Resolvins, 597–598

# I-42INDEX

Respiratory disease, Oyster mushroom for, Respiratory effects of Cannabis, of Lobelia inflata (Indian tobacco), Respiratory function, normal, in hyperventilation syn- drome/breathing pattern disorders, Respiratory homeostasis, Respiratory protection, Cordyceps for, Respiratory support, Oyster mushroom for, Respiratory syncytial virus (RSV), 916–917 Respiratory system. See Lungs/respiratory system Rest, 19b Rest-based training method, 288–289 Rest-based workout, Restless legs syndrome (RLS), 1491–1492, 1719–1720 Hypericum perforatum (St. John’s wort) for, Valerian for, Resveratrol, 1371, 1800–1801 for endometriosis, for rheumatoid arthritis, 1774–1775 Retinoids, Retinol, 950, Retinopathy, diabetic, 626, 828, 1274, 1283–1284 Retrograde flow, endometriosis and, Revulsive effect, of hydrotherapy, Rh factor, Rheology, Rheum rhaponticum (Siberian rhubarb), Rheum species, Rheumatic diseases biological disease-modifying antirheumatic drugs, 1772 synthetic disease-modifying antirheumatic drugs, Rheumatoid arthritis (RA), 1767–1776.e2, 227–228 biological disease-modifying antirheumatic drugs for, 1772 boron for, botanical medicines for, 1774–1776 classification criteria for, 1770t corticosteroids for, 1771–1772 counseling/psychological therapy, dehydroepiandrosterone for, diagnosis, 1767, 1770–1771 diet, 1772–1773, erythrocyte sedimentation rate monitoring, exercise for, fasting and, fish oils for, general considerations, 1767–1770 hydrotherapy for, nonsteroidal anti-inflammatory drugs and cyclooxy- genase inhibitors for, pathogenesis, 1767–1770 abnormal estrogen levels, abnormal gut permeability, autoantibody production, decreased androgen levels, dysbiosis and small intestinal bacterial overgrowth, 1769 environmental factors, microbial influences, 1768–1769 oxidative stress, xenobiotics and autoantibody production, 1769–1770 physical medicine for, 1775–1776 psychological aspects of, 1775–1776 standard medical therapy for, 1771–1772 supplements, synthetic disease-modifying antirheumatic drugs for, 1772 Tanacetum parthenium for, therapeutic approach, therapeutic considerations, 1772–1776 Rheumatoid factor, Rhinovirus, 17b Rhode Island Medical Journal, Rhodiola rosea (arctic root), 1045, 1077, Rhus toxicodendron, Rhythmic traction technique, 384t RIA. See Radioimmunoassay Riadore, J. Evans, Riboflavin (vitamin B 2 ), status determination of, Ribose, Rice Diet, Ricin, Ricinus communis (castor bean extract), Rickli, Arnold, Riley, Joe Shelby, 37, Rishi Kapila (realized beings), Risk factors Alzheimer’s disease, 1095t cardiovascular, carpal tunnel syndrome, of cervical dysplasia, 1214–1215, 1214t colorectal cancer, for coronary artery disease and stroke, of diabetes mellitus, 1264–1266, 1267b diet-related, elevated cholesterol, endometrial cancer, for endometriosis, excessive salt intake, gallstones, 1330–1332 of human papillomavirus, 1214–1215, 1214f of hyperthyroidism/Graves’ disease, 1400–1401 leukemia, morbidity due to obesity, 1606b for multiple sclerosis, 1589–1590 of osteoporosis, 1635–1638 of otitis media, 1660–1661, 1661f for Parkinson’s disease, for pelvic inflammatory disease, pesticide exposure, 365–366 pregnancy, of sunbathing, thrombosis, of vitamin E (tocopherols), 749–750 Ritucharya (seasons), RLS. See Restless legs syndrome RM. See Raw material RNA, 140, 165f RNS. See Reactive nitrogen species Robert formula, Rockefeller Foundation, 30, Rockefeller Medicine Men (Brown), Role of healing, Roman snail, 354, 360t ROS. See Reactive oxygen species Rosacea, 1777–1780.e1, 1777f B vitamins for, description and stages, diagnosis, diet, etiology, food allergy, Helicobacter pylori, hypochlorhydria, general considerations, 1777–1778 general recommendations, physical modalities and devices for, supplements, therapeutic approach for, 1779–1780 therapeutic considerations for, 1778–1779 topical azelaic acid (AzA) for, zinc for, Rosemary, 1224–1225 Rosenthal, Saul, Rosmarinus officinalis (rosemary), 1388b Rotation diet, 379–381.e1 Rotation Diet Master Chart and Plan, 1877t Rotenone, Rotterdam criteria, Roundup, Royal jelly, RPGN. See Rapidly progressive glomerulonephritis RRIs. See Recurrent respiratory infections RSI. See Reflux Symptom Index RSIs. See Repetitive strain injuries RSV. See Respiratory syncytial virus Rubor (redness), Ruscin, 836f Ruscogenin, 836f Ruscus aculeatus (butcher’s broom), 836–840.e1, 1755, 1852–1853 for anticancer effect, for antielastase effect, for antihypoxic effect, for antiinflammatory effect, for antimicrobial effect, chemical composition, 836, 836f–837f Ruscus aculeatus (butcher’s broom) (Continued) for chronic venous insufficiency, 837–839, 838t clinical applications, 837–839 description, for diabetic retinopathy, dosage, drug interactions, for edema and varicosities, 839, 840t for fibrinolytic effect, for hemorrhoids, history and folk use, for lymphatic flow effect, pharmacology, for premenstrual syndrome, for soft tissue injuries, toxicology, for vasoconstrictive effect, Rush Medical School, 38–39

# S

Saccharides, digestion of, Saccharomyces, Saccharomyces boulardii, 1017, 1173–1174, 1173b, Sacral thrust test, Sacroiliac joint (SIJ), 336–337 SAD. See Seasonal affective disorder S-adenosylhomocysteine, 987, 987f S-adenosylmethionine (SAMe), 841–844.e2, affective disorders and, available forms, chemical composition, 842f clinical indications, 841–844 for depression, 841–842 dosage, drug interactions and contraindications, for fibromyalgia, for hepatitis C, for liver disorders, 843–844 for migraine, for osteoarthritis, 842–843, 1627, pharmacology, toxicology, Sadness, Unani medicine for, Saffron, Saiko-keishi-to, Salai guggul gum (Boswellia serrata), 1128, 1482–1483, 1483t, Salicylates, for urticaria (hives), Salivary glands, Salix alba (white willow), Salmonella species, 369, 1224, glyphosate and, Salt, kidney disease and, Salt pipe treatment, for pneumonia and bronchitis, 1200–1201 Salt precipitation method, in glandular preparations, 301–302 Salvia militorrhizae, for chronic kidney disease, Salvia officinalis, for herpes simplex virus, Samkhya philosophy of creation, Samskara (refinement), Samyoga (combinations of drugs), Sanguinaria canadensis (bloodroot), 266, 1218, Sanguine temperament, 398t Sanitarium, 31, 36, Santonin, Saponin, SAR. See Society for Acupuncture Research Sarcoma cells, beta-lapachone for, Sarcopenia, 1781–1803.e19 accelerated myonuclear apoptosis, altered endocrine function, 1785–1786 altered microRNA expression, anabolic hormone repletion, 1795–1796 angiotensin-converting enzyme inhibitors, 1794–1795 botanical medicines for, 1801–1803 categories of, 1787–1788, 1788t chronic low-grade inflammation, classifications, 1786–1787 comorbidities, developmental influences of, 1783–1784 diagnosis, 1781, 1786–1793 diet for, differential diagnosis,

# I-43INDEX

Sarcopenia (Continued) epidemiology of, etiology of, EWGSOP conceptual stages of, 1786, 1787t general considerations, 1781–1782 genetic influence of, impaired satellite-cell function, 1784–1785 lack of physical activity, mitochondrial dysfunction, molecular and biochemical basis of, 1782–1783 muscle mass assessment, 1790–1791 muscle mass/damage measurement, 1792–1793 muscle mass measurement, 1791–1792 muscle strength assessment, 1789–1790 myostatin and, 1785, neuromuscular function loss, nutritional status, 1786, 1793, 1794t nutritional supplements for, 1798–1801 operational definitions for, 1795t oxidative stress, 1785, pathogenesis of, 1782–1786 physical activity, physical medicine, 1802–1803 physical performance assessment, protein metabolism of, rapid screening SARC-F, standard medical therapy, 1794–1796 supplements for, therapeutic approach, 1802–1803 therapeutic considerations for, 1796–1802 Sarcosine, for epilepsy, SARMs. See Selective androgen-receptor modulators Sat (truth), Saturated fats osteoporosis and, in PCOS, Saturated fatty acids, 131–132 Satva (essence), Satva mind type, Sauna, 329, 329f for congestive heart failure, Sauna therapy, Sauna treatment, for toxic chemical exposure, Saw palmetto extract, Scalp psoriasis, 1763, 1765f Scandinavian Journal of Medicine, Science and Sports, Scarlet fever, Scars, SCC. See Squamous cell carcinoma SCFAs. See Short-chain fatty acids Scheel, John, Schilling test, Schisandra chinensis (shisandra), for PCOS, Schistosoma mansoni, Tabebuia avellanedae for, Schistosomiasis, Artemisia annua (sweet wormwood) for, Schizophrenia, Cannabis and, Schizosaccharomyces pombe, Schlichting, Henry J. Jr., 55, 61, 65–66 background on clinical practice, 65–66 becomes president, 66–67 and Western ANA, School of physicians (Atreya Sampradaya), School of surgeons (Dhanvantari Sampradaya), 257–258 Schroth, Johann, Schulze, William Charles, 50–51 Schweitzer, Albert, Scientific considerations in naturopathic medicine, 17b adaptive response in chronic illness, 18b role of environment in chronic illness, 17b suppression of body’s responses, 17b public and community health concerns, 19b toxemia, 22b Scientific medicine, 40, foundations of, history of, Scientifically valid method, Scleroderma, 374, Sclerotherapy, Scoliosis, Scopoletin, 884f Scott, Christopher, Scrotal (testicular) ultrasonography, 1459t Scudder’s alternative, 1837, Scurvy, Scutellaria species S. baicalensis (skullcap), 1388b S. lateriflora, SDB. See Sleep-disordered breathing Seasonal affective disorder (SAD) diagnosis, Hypericum perforatum (St. John’s wort) for, therapeutic considerations, Seasons (Ritucharya), Seaweed, in chemically induced illnesses, 279–280 Seborrhea, Seborrheic dermatitis, 1804–1806.e1 botanical medicines for, diagnosis, 1804, 1805f diet for, general considerations, homeopathic therapy for, nutritional supplements for, 1804–1806 supplements for, therapeutic approach, therapeutic considerations, 1804–1806 topical treatment for, Secretor genes, FUT1 and FUT2, Secretory immunoglobulin A (sIgA), 169–170 Sects Christian Science, history of new medical, nonallopathic, rise and fall of, Sedative effects, of Melissa officinalis (lemon balm), Sedatives, 1492, 1711b Sedentary lifestyle, male infertility and, Seeds, atherosclerosis and, 1137–1138 Selectins, Selective androgen-receptor modulators (SARMs), for sarcopenia, Selective Functional Movement Assessment (SFMA), 283–284 Selective GI antimicrobial activity, probiotics and, Selenium, 203, 1014, for acne vulgaris/acne conglobata, for alcohol detoxification/treatment, as antioxidant, 736–737 assay of, 1459t for cataracts, for cervical dysplasia, for endometriosis, for epilepsy, 1303, for female infertility, 1445–1446 hair mineral analysis for, for hepatitis viruses, 1363, for HIV/AIDS, 1384b for hyperthyroidism/Graves’ disease, 1403–1404 for hypothyroidism treatment, for male infertility, 1467, for osteoporosis, for PCOS, for periodontal disease, for rheumatoid arthritis, Selenoprotein P, as antioxidant, Self-actualization, 103–104 Self-declaration molecules, Self-determination theory, Self-healing mechanism inflammation, obstacles to cure, placebo response and, 88–89 power of life force in, stimulating of, 22–23 Self-talk, Seligman, Martin, 104, Seligman’s Attributional Style questionnaire, instructions in, overall scores in, results interpretation in, scoring key in, Senile macular degeneration, Senna, for constipation, Senses, in Ayurvedic medicine, 258–259 SEPAHAN. See Study on the Epidemiology of Psycholog- ical, Alimentary Health and Nutrition S-Equol, Serenoa repens (saw palmetto), 847–850.e2 for benign prostate hypertrophy, 849–850, 849t for benign prostatic hyperplasia, 1193–1194 chemical composition, for chronic prostatitis, clinical applications, 848–850 description, 847, 847f–848f dosage, drug interactions, history and folk use, for male-pattern baldness, pharmacology, 848, 848f toxicology, Serotonin, 660, 660b blood levels of, 661t 5-hydroxytryptophan (5-HTP) and, 666, 666t low-serotonin theory, migraine headaches and, 1576–1577 Serotonin precursor, 1490–1491 Serotonin reuptake inhibition, Hypericum perforatum (St. John’s wort) in, Serotonin syndrome, Hypericum perforatum (St. John’s wort) and, SERPINE1 gene, Serratia peptidase, for bacterial sinusitis, Serum biomarkers, for sarcopenia, Serum electrolytes, in fasting, Serum nutrient testing, Sesquiterpene lactones, 874f Set points in homeostasis, 18b Severe sarcopenia, Sex hormone single-nucleotide polymorphism, Sex hormones, 1711b Sex steroid hormones, Sexual activity during menses, urinary tract infections related to, 891–892 Sexual practices, role in chronic illness of, 17b SFMA. See Selective Functional Movement Assessment Shakti, Shatavari. See Asparagus racemosus Shellfish consumption, toxic metal exposure with, Shelton, Herbert M, Shew, Joel, Shigella, 1224, 1423–1424 Shiitake (Lentinula edodes), 687, 687f Shingles, Shiva (god of destruction), Short-chain fatty acids (SCFAs), 810–811 Short guidance report, 1022–1023, 1023t Short physical performance battery, for sarcopenia, 1789–1790 Short-term starvation (STS), 974–975 Sho-saiko-to, 1365–1366 Shrira (soundness of body), Siberian rhubarb (Rheum rhaponticum), SIBO. See Small intestine bacterial overgrowth Sickle cell anemia, Sickle cell disease, glutamine for, Sickness behavior, sIgA. See Secretory immunoglobulin A Sigma 1-receptor activation, Hypericum perforatum (St. John’s wort) in, Sigma Phi Kappa, Signaling cascades, Signatures, doctrine of, SIJ. See Sacroiliac joint Silent Spring (Carson), Silicon, for osteoporosis, 1650–1651 Silybum marianum (milk thistle), 851–855.e1, absorption studies, chemical composition, 851, 852f for chemically induced liver damage, for cirrhosis, clinical applications, 853–855 clinical studies, description, dosage, drug interactions, as galactogogue, for gallstone treatment, for gallstones, for hepatitis viruses, 1364–1365, hepatoprotection, 851–853 history and folk use,

# I-44INDEX

Silybum marianum (milk thistle) (Continued) for HIV/AIDS, 1385b, 1388b, for metabolic syndrome, 854–855 for nonalcoholic fatty liver disease, for nonalcoholic steatohepatosis, pharmacology, 851–853 for psoriasis, 854, toxicity, for type 2 diabetes, 854–855 for viral hepatitis, when bound to phosphatidylcholine, Silymarin, Simmons, George, 38–39 Singleplex extracts, Sirtuins (SIRTs), Sitz baths, 325–326, 1752, Skeletal changes, with hypothyroidism, Skin Aloe vera (Cape aloe) in, 424–425 cancer, care during fasting, changes with hypothyroidism to, emollients, microbiome, 1757–1758 peat therapy, response to peat therapy by, vitamin K and elasticity of, 942–943 Skin debridement/burn wounds, bromelain for, Skin diseases, herbs for, 406, 407t Skin distraction techniques, for soft tissue manipulation, 384 Skin health, galactooligosaccharides and, Skin infections, Melaleuca alternifolia (tea tree) for, SLE. See Systemic lupus erythematosus Sleep hepatitis viruses and, before lactose malabsorption testing, low serotonin levels affecting, 660b position, and kidney stone formation, during pregnancy, 1719–1720 Sleep apnea, Sleep-disordered breathing (SDB), Sleep disorders, Cannabis for, Sleep disruption, melatonin for, Slippery elm (Ulmus fulva), for constipation, for gastroesophageal reflux disease, Slow-transit constipation, Small intestine bacterial overgrowth of adverse food reactions, rheumatoid arthritis and, digestive/absorptive capacities of, digestive physiology, 228–229 stasis of contents of, Small intestine bacterial overgrowth (SIBO), 113–117.e2 addressing underlying cause, alternatives to antibiotics, antibiotics for, breath testing, 115–116 false-negative results, false-positive results, hydrogen versus methane, interpretation, when to consider, 114b conditions associated with, description of, dietary support for, endoscopy, etiology, 114f, 114b herbal antibiotics for, 116–117 normalization of intestinal motility for, pathophysiology of, 113–114 restoration of gastric acidity for, signs/symptoms, 114–115, 114b therapeutic considerations/approaches, bacterial eradication for, Smell (earth), Smilax species (sarsaparilla), 845–846.e1, 266–267, chemical composition, 845, 846f description, dosage, drug interactions, history and folk use, pharmacology, 845–846 Smilax species (sarsaparilla) (Continued) for psoriasis, toxicology, Smoking (tobacco) affective disorders, atherosclerosis and, 1132–1133, 1134b Cannabis and, exposure before lactose malabsorption testing, human papillomavirus and, male infertility and, 1462–1463 pelvic inflammatory disease and, peptic ulcer disease and, periodontal disease and, during pregnancy, 1721–1722 as risk factors for osteoporosis, risk/benefit for Parkinson’s disease, Smooth muscle constriction, Smooth muscle relaxation, Smooth muscle-relaxing activity, of Angelica species, Snoring, Social media, affective disorders, Social stress, Society for Acupuncture Research (SAR), 251, Socioeconomic health determinants, 19b Sociopolitical Status of U.S. Naturopathy at the Dawn of the 21st Century, SOD. See Superoxide dismutase Sodium, 198–199 hair mineral analysis for, intake of, 1521–1522, 1521f osteoporosis and, Sodium bicarbonate, 1045–1046 Sodium curcuminate, antiinflammatory effects of, Sodium intake, 125, 198, 368, 1053, Soft tissue approximation end-feel, Soft tissue manipulation, 382–385.e1 diagnostic methods, 383–384 aberrant movement patterns, identification methods, health implications of, overview, pathologies of soft tissues, 383–385 potential of, 384–385 techniques, 384, 384t terminology, “Softer option” model, Soluble endothelial cell markers, Soluble transferrin receptor (sTfR), Solute carrier family 39 member 13 (SLC39A13), Solvent primer, 728–729 Solvent toxicity, neurotoxins, Solvents, 275–276, 276b exposure, in pregnancy, 1723t–1724t in infertility, SOPs. See Standard operating procedures Sorbitol, intracellular accumulation of, Soundless sound (Aum), Soundness of body (Shrira), Soundness of mind (Manas), Soundness of soul (Atma), Soy for endometriosis, fibrocystic breast disease and, Soy protein, antioxidant activity of, blood pressure and, 861–862 body composition and, 862–863 body weight and, 862–863 cadmium content of, for cancer, 863–865 cardiometabolic disease factors of, for cardiovascular disease, 860–861 chemical composition, 856–858, 856f–857f, 857t for cholesterol metabolism, clinical applications, 860–866 for cognitive function, constituents/compounds, 859t coumestans, phytates, 857–858 phytosterols, 857–858 protease inhibitors, 857–858 saponins, 857–858 drug-nutrient interactions, 866–867 for fatty liver disease, glucose metabolism and, 862–863 Soy protein (Continued) hormonal effects in adults, 858–860 in infants, 859–860 isoflavones, 743, 856, 856f, 857t, 858f, 1558t absorption, metabolism, excretion of, classification of, 856–857 content of, mechanism of action of isoflavones, for menopause, 865, for osteoporosis, 865–866 pharmacology of, 858–860 polyphenol classification, 857f research on health benefits, safety considerations, Spagyric medical systems, Special Delivery (Benson), Sperm count/motility, 498–499 Sperm dysfunction, in male infertility, Spermicide, Spinal cord injuries, Spinal cord reflex, Spinal Manipulation (Bourdillion), Spirits, 20, Spiritual care, Spiritual correspondences, in Unani medicine, Spiritual healer, Spiritual lore, black seed and, 403–404 Spiritual stressors, in total load, Spirituality, 386–390.e1, 386f advancing research on, definitions, 386–387 in health care, 387–388 as health determinants, 19b health effect, research, 388–389 Spirulina, 1046, 1046b Spirulina platensis (blue-green algae), 1046, 1046b, 1388b Spitler, H. Riley, Spleen extracts, in glandular therapy, 303t–304t, Splinting, Spongiform encephalopathy, glandular therapy for, Sports nutrition, 1035–1048.e7, 1037b–1038b arginine for, assessment, 1039–1040 beta-alanine for, 1041–1042 beta-hydroxy beta-methylbutyrate for, branched chain amino acids, 1042–1043 caffeine intake, cold water immersion for, creatine monohydrate, 1044–1045, 1044b critical evaluation of ergogenic aids, diet concerns for athletes, 1036–1037 fat intake, green tea extract for, health concerns for athletes, intermittent fasting, ketogenic diet, 1035–1036 macronutrient ratios, magnesium for, 1047–1048 nutritional supplements for, 1040–1048 performance, recovery, and nutrient timing, protein intake, 1037, 1046–1047 quercetin for, Rhodiola rosea for, ribose for, sodium bicarbonate for, 1045–1046 Spirulina for, 1046, 1046b vitamin and mineral intake, 1038–1039 water intake, Sprains, Springing technique, 384t Springy end-feel, 337–338 Spurling’s maneuver, Squalene, Squamous cell carcinoma (SCC), Squamous intraepithelial lesions of cervix, Stachybotrys, Staden, Carola, Staden, L., Stage 1 hypertension, Stage 2 hypertension, Stair climb power test, for sarcopenia, Standard American diet (SAD), 1638–1640 Standard blood chemistries, 1459t

# I-45INDEX

Standard medicine (biomedicine), 15, Standard operating procedures (SOPs), Standardization of food allergy tests, of hair mineral analysis, for herbal medicine, of pancreatic enzymes, Standards, medical/professional, 40, 45–46 Stanols, for lowering cholesterol levels, Staphagine, Staphylococcus aureus, Starchy vegetables, State Licensing of Health Occupations, 44, State of the industry, 722–723 State of wellness, Statins, 240, 940, Stearic acid, Steatohepatitis, nonalcoholic, 1600–1604.e3 Steroid injection, sTfR. See Soluble transferrin receptor Still, A. T., 36, Stimulants, Stomach, digestive physiology, Stone root (Collinsonia canadensis), Stool analysis, for candidiasis, 1220–1221 Stool testing, lactose malabsorption testing, Stool transit time, Storage, of carotenes/carotenoids, Storage proteins, Strain-specific synbiotic combinations, Strains, Streptococcal pharyngitis (strep throat), 1814–1816.e1 bacteriotherapy for, botanical medicines for, considerations for, 1814–1815, 1815f diagnostic summary of, Hydrastis canadensis and Echinacea species for, lactoferrin for, local treatment of, Pelargonium sidoides for, probiotics for, supplements for, therapeutic considerations in, 1815–1816 vitamin C for, 1815–1816 Streptococcus pneumoniae, Stress inoculation, Stress management for cancer, for PCOS, 1705–1706 Stress proteins, Stress urinary incontinence, Stress/stress management, 1049–1055.e1, 350–351 for acne vulgaris/acne conglobata, body calming, 1051–1052 botanical medicines for, 1054–1055 breathing exercise, 1051–1052 chemical response to, for chronic fatigue syndrome, 1229, 1230f coping styles, 1742, 1742b definition of, for diabetes mellitus, 1276–1277 diagnostic considerations, 1050–1051 negative coping patterns, 1051b Social Readjustment Rating Scale, 1050t stress response, 1051b diaphragmatic breathing for, 1052b and diet, 1064f dietary guidelines for, diseases linked to, 1050b Eleutherococcus senticosus for, endometriosis and, 1287–1288 exercise for, fight or flight response, galactooligosaccharides and, 804–805 general adaptation syndrome, glycemic volatility and, as health determinant, 19b, healthy view of, 1049–1050 immune support and, immune system effects of, improving communication for, 1052b influence on gut flora of, irritable bowel syndrome and, 1501, 1505f kidney stone formation and, Stress/stress management (Continued) lifestyle factors in, maladjustment to, meal planning, for menopause, myocardial ischemia triggered by, negative coping patterns for, 1051b nutritional and botanical support, 1053–1055 nutritional supplements for, 1054–1055 Panax ginseng (Korean ginseng) for, 757–760 peptic ulcer disease and, phosphatidylserine for, physiological and psychological, placebo effect of, 93–94 during pregnancy, premenstrual syndrome and, programs, for psoriasis, relaxation response, 1051b result of, 1064f rosacea and, social, therapeutic approach, 1051–1053 time management for, 1052b Stretching exercises, 1277–1283 Stretching technique, 384t Striae gravidarum, Stringy end-feel, Stroke Belt and Buckle, Strokes citicoline (CDP-choline) for, 520–521 fish oils for, menopause and, percentages by ABO blood group, risk factors for, subsequent, vertebrobasilar, 335–336 Stroma, Strontium citrate, 1652–1653 Structural integrity, 3f, Struvite stones, STS. See Short-term starvation Study of the Healing Arts With a Particular Emphasis Upon Naturopathy, Study on the Epidemiology of Psychological, Alimentary Health and Nutrition (SEPAHAN), Styrene/ethylbenzene, 218t–219t Subcellular interventions, Subclinical celiac disease, Subclinical inflammatory state, 19b Suberic acid, Substance use, in pregnancy, 1720–1724 Substantia nigra cell death, Succinic acid, glyphosate and, Sucrose, Sugar ASD and, attention deficit hyperactivity disorder (ADHD) and, 1159–1160 avoidance of, 1333–1334 in PCOS, yeast problem with, Sugar intake glycemic index for, 1411t osteoporosis and, for treatment of acne vulgaris/acne conglobata, in treatment of candidiasis, Sugar intolerance, Sugar probes, factors that affect excretion of, “Suggestive therapeutics”, Suicidal ideation, 1386–1387 Sulfa-drug antibiotics, 1711b Sulfate, urinary, 243–244 Sulfated proteoglycans, Sulfites, 1828–1829 Sulfur, Sunlight/sunbathing during fasting, in fasting, for psoriasis treatment, 1762–1763 risks of, sunblock, Superoxide dismutase (SOD), 736, 1773–1774, Supine straight-leg raise (Lasegue) test, 336f Supplements for atherosclerosis, for bacterial sinusitis, 1187–1188 for benign prostatic hyperplasia, for gastroesophageal reflux disease, 1342–1343 Supplier, definition of, Supplier certification, compliance guide and questionnaire in, 1882, 1883f Support Adams (belt test), 336–337 Suppositories, Suppression of symptoms, 17b, 83, 83b Surgery cardiac, 530–531 for carpal tunnel syndrome, for hemorrhoids, 1751–1752 for overactive bladder, postsurgical inflammation, bromelain for, in Unani medicine, 404–405 for uterine fibroids, Surgical treatment, for varicose veins, Survey of Naturopathic Schools, Susceptibility gene, Sushruta Samhita, 235, 257, Swallowing, Swank/low-saturated-fat diet, 1594–1595 Sweet wormwood. See Artemisia annua Swelling (tumor), Swimmer’s ear, Sympathetic nervous system, Symphytum officinale (comfrey), 1366, Symptomatic epilepsy, Symptoms aggravation of, 83–84 interpretation of, meaning of, morbid, suppression of, 17b, 83, 83b Synbiotics, Syndrome X, Synergist, The, 60–61 Synergist: Western States College Voice of the Student Body, The, Synovitis, 1770t Synthetic chemicals, Synthetic disease-modifying antirheumatic drugs, Synthetic pesticides, Synthetic retinoids, for lichen planus, Syphilis, Systemic enzyme therapy, Systemic lupus erythematosus (SLE), 124, 227–228

# T

T cells, 162, CD4 T helper subsets, 162–163 food allergy responses to, markers of activation of, 163t measures of, regulatory, subpopulations, 162–163 virus-free, Tabebuia avellanedae, 868–872.e2, 869f as antidepressant, anti-inflammatory activity of, antimicrobial activity of, 869–870, 870t antineoplastic effects of, 870–871 for cancer, chemical composition of, clinical applications of, description of, dosage, drug interactions, history and folk use of, 868–869 pharmacology of, 869–872 quercetin in, 871–872 quinones in, 869b toxicology, Tai chi, multiple sclerosis and, Talk test (exercise), 286–287 Tamas (inertia), Tamas mind type, Tamoxifen, Tanacetum parthenium (feverfew), 873–875.e1, 1583, 1586 chemical composition, 873, 874f clinical applications,

# I-46INDEX

Tanacetum parthenium (feverfew) (Continued) description, 873, 873f–874f dosage, drug interactions, history and folk use, for migraine headache, 874–875 pharmacology, for rheumatoid arthritis, toxicity, Taraxacum officinale (dandelion root), 876–878.e1, anticancer and immune-enhancing effects, for blood sugar control, chemical composition, 876–877, 877f clinical applications, description, for diabetes, digestive effects, diuretic and weight loss effects, dosage, drug interactions, for gallstone treatment, 877, history and folk use, as liver tonic, pharmacology, 877–878 toxicity, Taraxasterol, 877f Taraxerol, 877f Tartaric acid, Tartrazine, Taste (Water), Taurine, 990f, 993, 1073, 1302, for ASD, Taut end-feel, 337–338 Taxane-related neuropathy, melatonin for, Taxines, Taxus brevifolia (Pacific yew), 879–882.e1, 879f alopecia and, chemical composition, paclitaxel, 879, 880f clinical applications, description, drug interactions, 882, 882b history and folk use, medical problems affecting use of, 882b pharmacology of, 880–881 side effects of, toxicity, Taylor, Andrew, 31, TDLU. See Terminal duct lobular unit Teas antioxidant activity of, 744–745 black versus green, flavonoids for cancer prevention, Hibiscus sabdariffa, 1398–1399 Melissa officinalis (lemon balm), world production of, 466t Teleological behavior, of organisms, Teleology, in Unani medicine, Temperaments, 397, 398t Temperate phages, Tender points (soft tissue), Tendon end-feel, Tennessee State Medical Association, TENS. See Transcutaneous electrical nerve stimulation Tension headache, melatonin for, in children, Teratogenicity, Teratozoospermia, 1454t Terminal duct lobular unit (TDLU), Terminalia arjuna, for congestive heart failure, Terpenes, for gallstone treatment, Testosterone, 287–288, 1067–1068, 1384b for ASD, for sarcopenia, Tethered capsule repeat challenge, Tetrahydrobiopterin, Tetrahydrocannabinol, Tetraplegia, melatonin for, Tetraploid cells, Texas medical wars, 69, 71, 75–76 1957, 75–76 Textbook of Functional Medicine (Jones), Textbook of Natural Medicine (Bastyr), Textbook of Pathology (Boyd), TFA. See Thomsen-Friedenreich antigen TFAs. See Trans fatty acids Thalassemia, 1104, 1104f Thea sinensis (green tea), L-Theanine, for attention deficit hyperactivity disorder (ADHD), T-helper cells, 111, Theories/theoretical models be’ champ, Eclectic School of Medical Theory (Beach), etiological theories, 1288–1289 five elements (phases) theory, 253–254 free radical theory of aging, 733–734 gate control theory, germ theory, 28, naturopathic medicine, 12–13, 15–17, 24, in acute illness, 16–17 in chronic illness, core of, 13–14 modern theory/process of development, 13–15 in Unani medicine, 396–402 doctrine of the seven naturals, 397–400, 397f four different temperaments, 398t invisible vis (quwwa), 396–397 vis medicatrix naturae, “Unifying Theory of Disease” (Harvard Health Letter), 18b Theracurmin, 555, 558t Therapeutic monitoring, 948–954.e3 Therapeutic order, 12, 20–24, 21b Therapeutic relationship, 95b, Therapeutic response variables, Therapies, metabolism-regulating therapies, 1323–1324 Thermal chambers, in Crinnion Depuration Protocol, 280 Thermal effects, of water, Thermal therapy, Thermogenesis Capsicum frutescens (cayenne pepper) for, diet-induced, 1612, 1613f Zingiber officinale (ginger), Thiamine (vitamin B 1 ) for epilepsy, status determination of, Thiamine tetrahydrofurfuryl disulfide, for ASD, Thiolase, Thiols as antioxidants, magnesium, N-acetylcysteine and glutathione, zinc, 741–742 Thioredoxin, 737–738 Thomas, Lewis, Thomsen-Friedenreich antigen (TFA), Thomson, Samuel, 27, Thomsonian doctors (“botanics”), Thomsonianism, 27, Thrombomodulin, Thrombosis, 351, Thrush, oral, β-thujone, Thunder god vine (Tripterygium wilfordii Hook F), 1775 Thyme, 1224–1225 Thyme essential oil (Thymus vulgaris), 1859, 1859f Thymic stromal lymphopoietin, atopic dermatitis (eczema) and, 1149–1151 Thymus extracts, in glandular therapy, 303t, 305–306 for hepatitis viruses, 1364, Thyroglobulin, Thyroid for ASD, 1182–1183 cancer of, soy protein and, fibrocystic breast disease and, 1316–1317 goiter, goitrogens, 1403, Hashimoto’s thyroiditis, 227–228, replacement of, urticaria (hives) and, Thyroid antibodies test, Thyroid disruptors, 1416f Thyroid effects, of Melissa officinalis (lemon balm), Thyroid extracts, in glandular therapy, 303t, Thyroid function tests, Thyroid hormone replacement medications, for osteoporosis, Thyroid hormone therapy, 1324–1325 Thyroid hormones, 1067, Thyroid stimulating hormone (TSH), 1459t Tidd, Jacob, Tight junctions, 168–169 Tilden, John H., Time conscious workouts, Time management, 1052b Time of day (Dincharya), Timed up and go (TUG), Tincture of opium (laudanum), Tinctures, Tinel’s sign, Tinnitus, melatonin for, Tissue damage Echinacea species, role of apoptosis in, Tissue distribution of vitamin K, 921f of vitamin K 1 , Tissue mobilization, Tissues (Dhatus), 257, Tizanidine, TNS. See Trigeminal nerve stimulation To know (Khya), Tobacco, oxidative stress and, Tollem causum, 95–97, 95b Toluene exposure, in pregnancy, 1723t–1724t Tongue, appearance of healthy, Tonics, 845, Topical melatonin, for breast irradiation dermatitis, Topical vitamin A, for erythema multiforme (EM), Tormentil root (Potentilla tormentilla), 1428, Total dietary fat intake, in pregnancy, Total Wellness (Pizzorno), Touch, healing power of, Touch (Air), Toukuwan, Tower, Donald B., Toxemia, 22, 22b, Toxic burden, 269–270, 270t–271t Toxic chemicals, 215–222.e2 2, 4-dichlorophenoxyacetic acid, 218t–219t, 220, 220f disease and, 216, 217f glyphosate, 218t–219t, 219–220, 219f indications for, 216, 218t–219t metallic, nonmetallic, treatment of exposure from, 221–222 organophosphates, 218t–219t, 221, 221f toxic metals and, in urine, 218t–219t Toxic element screening, 1459t Toxic exposure metabolites, Toxic metal poisoning in infancy, ASD and, Toxic metals, 733, atherosclerosis and, glaucoma and, kidney disease and, Toxicant exposure, Toxicants, 270t Toxicology/toxicity of Allium cepa (onion), Allium sativum (garlic), Ama, in Ayurvedic medicine, Angelica species, of antioxidants, of Artemisia annua (sweet wormwood), assessment for rheumatoid arthritis, of bee products, of Cannabis, of carnitine/L-carnitine, carotenes/carotenoids, 450, of Centella asiatica (Gotu kola), of Cimicifuga racemosa (black cohosh), 513–514 of citicoline (CDP-choline), exacerbation of porphyrias by, 1711b fish oil and, 609–611 of Melaleuca alternifolia (tea tree), neurotoxic chemicals, 1298–1299 of Panax ginseng (Korean ginseng), 766–767 of pancreatic enzymes,

# I-47INDEX

Toxicology/toxicity (Continued) persistent organic pollutants, 1269, 1269f of phage therapy, of phosphatidylserine, during pregnancy, 1722–1724, 1723t–1724t for protection against, Toxin avoidance, for menopause, 1559–1560, 1559f Toxin exposure, ASD and, 1170–1171 kidney stones and, Toxin reduction, probiotics and, Toxins, hypothyroidism and, 1415–1416 Trace elements, Trace minerals, immune support by, Traction techniques, TRAIL. See Tumor necrosis factor-related apoptosis inducing ligand Trall, Russell, 28–29 Trametes versicolor, 683f Trance, Trans fats in endometriosis, osteoporosis and, Trans fatty acids (TFAs), Transaminase enzymes, Transcellular transport pathway, Transcellular uptake, Transcutaneous electrical nerve stimulation (TENS), 342–343, 343t Transcutaneous tibial nerve stimulation, for overactive bladder, Transferrin, Transformation, of carotenes/carotenoids, 444–445 Transport, of carotenes/carotenoids, Transport mechanisms, 385, 912–914, 920, 921f, Transport proteins, Transrectal ultrasonography, 1459t Transsulfuration pathway, of methionine/homocysteine degradation, 986f, Traumatic head injuries, citicoline (CDP-choline) for, 521–522 Travelers’ diarrhea, probiotics and, Treatment methods choosing therapies, prima non nocerum, treat the whole person principle, 81b Treatment of Epilepsy by Mistletoe, The (Colbatch), Treg cells, 162t, Tremella aurantia, Tremella fuciformis, Tremella mesenterica, Triacetyluridine (TAU), affective disorders and, Tribulus terrestris (tribulus), 1450–1451, 1470–1472 for PCOS, Trichomonal vaginitis, Trichomonas, Trichomoniasis (Trichomonas vaginalis), 1817–1820. e1, considerations for, conventional treatment for, diagnosis, 1817–1818, 1818f diagnostic summary of, diet for, 1819–1820 lifestyle for, in men, 1818, 1819f nutritional supplements for, 1819–1820 therapeutic approach in, therapeutic considerations for, 1818–1820 topical treatments for, topical trichomonacides for, 1819–1820 in women, Tridosh physiology, Tridosha, Trifolium praetense (red clover), 1562–1563 Trigeminal nerve stimulation (TNS), Trigeminal neuralgia, Trigger points, 344, Triggers for apoptosis, 119–120 in functional medicine model, 5–6 common, 5–6 triggers and provocation of illness, 5–6 Triglycerides, elevation of, Trigonella foenum-graecum L. (fenugreek seed), for PCOS, Tripterygium wilfordii Hook F (thunder god vine), 1775, 1839 Triterpene compounds, 502f Triterpenoids, 680, 680f Trowell, Hugh, Trunk flexion test, Truss, Orion, Truth (Sat), Trypanosoma cruzi, Tabebuia avellanedae for, Trypsin, 771b secretion, Tryptophan hydroxylase 1 (TPH1), Tryptophan hydroxylase 2 (TPH2), Tryptophan/L-tryptophan, 237, 1070f, 1072–1073, for asthma treatment, 5-hydroxytryptophan (5-HTP) versus, for insomnia, 1490–1491 metabolism of, 658, 659f urine indican test, 248, 248f TSH. See Thyroid stimulating hormone Tuberculosis (TB), TUG. See Timed up and go Tui na massage, for Parkinson’s disease, 1672–1673 Tumor (swelling), Tumor necrosis factor-related apoptosis inducing ligand (TRAIL), Turkey tail (Trametes versicolor, Coriolus versicolor, Kawaratake, Yun Zhi), 683f Turmeric/curcumin. See Curcuma longa Turnera diffusa (damiana), 1471–1472 Turska’s formula, 2000-Calorie diet, 1872t Tylophora asthmatica leaves, for asthma treatment, Type 2 diabetes, melatonin and zinc for, Tyrosine, 1073, 1074t, 1418–1419

# U

U. S. Department of Agriculture (USDA) “Eating Right Pyramid”, food additives, nutrition education, U. S. Department of Health, Education, and Welfare (HEW), UA. See Urinalysis Ubiquinone. See Coenzyme Q 10 UC. See Ulcerative colitis Ulcerative colitis (UC) Aloe vera (Cape aloe) for, butyrate enemas for, 1484, 1485t causative factors, 19b, mucin defects, definition of, 1473–1474 melatonin for, probiotics and, 817–818, 819t Ulcers Croton lechleri for, diabetes-related foot, 1274, 1284–1285 oral, 223, 224t Ulmus fulva (slippery elm), for gastroesophageal reflux disease, Ultrasound diagnostic, for sarcopenia, therapeutic, Ultraviolet light treatment, 1762–1763 Unani medicine, 391–408.e2 Arabic healing and Islamic genius in, for asthma, clinical quick notes in, 405–406 comparisons and contrasts to, 391–392, 392t–393t for coughing, description, 391–392 diabetes, herbs for, 406, 407t history of, 392–395 contributions and influences from antiquity, 392–393 Islamic medicine, 393–394, 394f post-Avicennan medicine, 394–395 for lethargy (chronic fatigue), for melancholy (sadness, low mood, or depression), 406 metaphysical and philosophical foundations of, 395–396 cosmology and human microcosm, 395–396, 396f epistemology and ontology, teleology and spiritual correspondences, Unani medicine (Continued) for nosebleed, practice framework of, skin diseases, herbs for, 406, 407t summary of, 406–408 techniques of inquiry and assessment, 400–402 of pulse, 400–401, 401f uroscopy, 401–402, 401f theory in principle, 396–402 doctrine of the seven naturals, 397–400, 397f four different temperaments, 398t invisible vis (quwwa), 396–397 vis medicatrix naturae, therapeutic modalities, 402–405, 402f environmental regimens for, 404, 404f food-based or dietary, infallible remedy for, 405, 406f, 406b pharmacy, Materia Medica, and Black seed in, 403–404, 403f–404f, 403t pneumatology and wellness for, surgery, cauterization, blood letting for, 404–405 for tinnitus (ringing in the ears), “Unifying Theory of Disease” (Harvard Health Letter), 18b United Kingdom, review of non-O status on thrombosis risk, “United States Infirmary”, Universal health care, Universal Naturopathic Directory and Buyer’s Guide, 32, 36 Universal Osteopathic College of New York, University of California San Francisco Center for Health Professions, 45–46 University of Utah, Survey of Naturopathic Schools, University of Washington, Upper limbs, tension signs, “Upstream” processes, Urates, 1351t Urea breath testing, Urge-suppression techniques, for overactive bladder, 1540 Urgency urinary incontinence, 1533–1534 Uric acid, 1350, 1350f, 1520t metabolism of, Urinalysis (UA) collection and culturing methods of, for cystitis, drug abuse testing, examination of, during fasting, for male infertility, 1459t for metal toxicity, 190–191 biomarkers of renal cadmium toxicity, unprovoked, microscopic examination of, Urinary dimethylphosphate (DMP), 271t Urinary incontinence, 1533–1534 Urinary indicators, of muscle mass/degradation, Urinary iodine, Urinary isoprostane, ASD and, Urinary neopterin, ASD and, Urinary odor reduction, Urinary organic acids, Urinary porphyrins, 245–247.e2, ASD and, description of, heme biosynthesis, 245, 246f, 247t porphyrias, types of, 246t porphyrinuria clinical applications of, in environmental exposure, 245–247 Urinary potassium, Urinary pyrroles, ASD and, Urinary sodium, Urinary tract infections (UTIs) ABH antigen and, Arctostaphylos uva ursi for, bacteriologic findings of, 1251t cranberry juice for, 891–892 as prophylactic, diagnosis of, incidence by age and sex of, 1251t

# I-48INDEX

Urinary tract infections (UTIs) (Continued) lactulose and, probiotics and, typical symptoms in women, 1251t Urine kidney stones and, physical changes in, 1520t reducing odor of, Urine culture, Urine dipstick, Urine indican test (Obermeyer test), 248–249.e1 clinical application of, 248–249 conditions associated with elevations of, 249t interpretation, 249, 249t Urine oxalate, Urine Wheel, 401–402, 401f Urogenital tract infections phage therapy for, probiotics and, 819–820 Urolithiasis, Uropathic infectious agents, 357t Uropathogens, adhesion of, Uroscopy, 401–402, 401f Ursolic acid, 829f Urtica dioca (stinging nettle), 883–886.e2, 884f for allergic rhinitis, for arthritis, for benign prostatic hyperplasia, 884–885, 885t, chemical composition, 883, 884f for chronic renal failure, clinical applications, 884–886 description, for diabetes mellitus, dosage, 886, 886t drug interactions, for galactagogue, history and folk use, pharmacology, 883–884 by plant part, 885t toxicity, Urticaria (hives), 1821–1833.e3, causes of, 1823–1830 bacteria, drugs, 1825–1826, 1825b environmental toxicants, 1826–1827 food-related, 1827–1829 infections, mast cell-derived mediators, 1823b physical, 1823–1825 viruses, vitamin D deficiency, 1829–1830 Chinese medicine/acupuncture therapy for, 1830, classification of, 1822f conventional drug treatment for, description, 1821, 1821f clinical aspects, 1824t immune defense model, 1827f diagnosis, 1831–1832 laboratory testing, 1831–1832 physical examination and history, 1831, 1831t provocation tests, 1826t test battery for, 1829t diagnostic summary of, diet for, 1828t, drugs for, 1832b pathophysiology of, 1821–1823 physical medicine for, psychological aspects of, 1830, supplements for, 1831–1832 ultraviolet light therapy for, U.S. Department of Labor’s Dictionary of Occupational Titles, U.S. Environmental Protection Agency (EPA), mold exposure assessment and, U.S. Homeopathic Pharmacopoeia, U.S. Medical Licensing Exam, 45–46 U.S. Secretary of Education, 45–46 Utah, naturopathic medicine in, early days, open up, shuts down again, Uterine fibroids, 1834–1839.e1 bioidentical progesterone for, botanical medicines for, 1837–1839 Echinacea/red root, Fraxinus/Ceonothus, Uterine fibroids (Continued) Gelsemium/Phytolacca, herbal extracts, Scudder’s alternative, 1837, Turska formula, combination therapies for, considerations for, 1834–1835 conventional medicine therapies for, cumulative incidence of, 1838f diagnosis of, diagnostic summary of, diet for, 1835–1836, environmental endocrine disrupters in, herbal medicines for, nutritional supplements for, 1836, risk factors for, 1835f surgery for, topical treatment for, Uterus intrauterine devices, intrauterine structural defects, 1570t UTIs. See Urinary tract infections Uva ursi (bearberry), 887–889.e1

# V

VA. See Vaccenic acid Vaccenic acid (VA), Vaccinations/immunization asthma and, history of fights against, Vaccinium macrocarpon (cranberry), 890–896.e3, 891f adverse effects, for antibiotic-resistant uropathogens, as antioxidant, for bacteriuria and pyuria, for benign prostatic hyperplasia, 1194–1195 for calcium oxalate urolithiasis, for cancer, chemical composition, clinical applications, 891–895 description, dosage, 895–896 drug interactions, for glycemic control, for Helicobacter pylori, history and folk use, 890–891 for insulin resistance, for neurogenic bladders, for oral bacteria, for overactive bladder, for peristomal problems, pharmacology, for sexual activity, 891–892 for spinal cord-injured patients, for urinary tract infections, 891–892, for vascular disease, 894–895 Vaccinium myrtillus (bilberry), 897–901.e2, 898f antiaggregation effect on platelets, antiulcer effects of, for atherosclerosis, capillary permeability, for cataracts, 900, chemical composition, clinical applications, 899–901 collagen stabilization, 897–898 description, for diabetes, dosage, drug interactions, for dysmenorrhea, effects on cancer cells, 898–899 for glaucoma, 899–900, history and folk use, for inflammatory bowel disease, 900–901 for inflammatory joint disease, for macular degeneration, for metabolic syndrome, for microscopical hematuria, for night vision and eye fatigue, for ophthalmological applications, 899–900 for periodontal disease, pharmacology, 897–899 for retinal degeneration, for smooth muscle relaxation, toxicology, Vag pack, Vaginal candidiasis, probiotics and, 820, 821t Vaginal depletion packs (vag packs), 1218, 1680–1681, 1886 Vaginal infections (vaginitis) ABH antigen and, Melaleuca alternifolia (tea tree) for, yeast, 442, Vaginal weight training, for overactive bladder, Vaginitis, 1840–1849.e4 atrophic, 1843, 1843b, bacterial vaginosis, 1841–1842, boric acid for, botanical medicines for, 1845–1846, considerations for, 1840–1841 diagnostic approach to, diagnostic summary of, dietary considerations for, 1843–1844, estrogens for, Humulus lupulus (hops) for, infectious vaginitis, 1841–1843, 1842t iodine for, kudzu (Pueraria mirifica) for, Lactobacillus probiotics for, 1846–1847 nutritional supplements for, 1844–1845, recommendations for, 1848–1849 therapeutic considerations for, 1843–1848 trichomoniasis, types of, 1841–1843 vaginal dehydroepiandrosterone for, 1847–1848 vulvovaginal candidiasis, 1842–1843, 1843f, 1843b Valepotriates, 902, 903f Valeriana officinalis (valerian), 902–905.e1 for anxiety and/or depression, chemical composition, 902, 903f clinical applications, 904–905 description, 902, 903f dosage, drug interactions, history and folk use, for insomnia, 904–905, for menopause, 905, pharmacology, 902–904 for rheumatoid arthritis, toxicity, Valsalva effect, Vanadium, Vancomycin-resistant enterococci, probiotics and, Vanilmandelic acid (VMA), Vaping devices, 1721–1722 Varicose veins, 1850–1853.e1 botanical medicines for, 1851–1852 conservative treatment for, diagnostic summary of, diet for, dietary factors, discussion on, 1850, 1851f etiology of, Vascular disease, microbial enzyme therapy for, Vascular protection, in smokers, melatonin for, Vascular system, exercise for, Vat constitutional type, Vat Dosha, 259, 261–262 VBS. See Vertebrobasilar stroke VC. See Vinyl chloride VCS. See Visual contrast sensitivity testing Vega testing, 138–139 Vegan diet, 381, 1124, 1650–1651 vitamin B 12 -deficiency anemia and, Vegetable intake, atherosclerosis and, 1138–1139 glycemic index for, 1411t oxalate content of, 1523b–1524b in pregnancy, vitamin sources, 911t, 922t–923t Vegetables, 1871, ASD and, green leafy and cruciferous, low-glycemic, starchy, Vegetarian diet, for gallstone treatment, and osteoporosis, 1650–1651 in pregnancy, 1716–1717 for rheumatoid arthritis,

# I-49INDEX

Velvet bean (Mecuna pruriens), Vendor certification, Venous insufficiency, 504–505, 617, Venous thromboembolism (VTE), 351, Ventricular premature beats (VPBs), coenzyme Q 10 for, 532 Verify, definition of, Vertebrobasilar stroke (VBS), 335–336 Veterans Affairs Normative Aging Study, Vibration technique, for soft tissue manipulation, 384t Vicia faba (fava bean), 360t Vietnamese folklore, Vinyl chloride (VC), Viral gastroenteritis, probiotics and, Viral infections apoptosis during, common cold, Hypericum perforatum (St. John’s wort) for, immune response to, 17b male infertility and, pancreatic enzymes for, 774–775 urticaria secondary to, Viral pathogens caliciviruses, cowpox virus, enterovirus, of infectious diarrhea, cytomegalovirus, Epstein-Barr virus, parvovirus, rotavirus, Norwalk virus, rhinovirus, 17b Viruses, antagonism against, Vis medicatrix naturae (healing power of nature), 20b, 45, 81b, 84–85, naturopathic medicine and, in placebo effect, in Unani medicine, Viscum album (European mistletoe), 906–909.e1 antineoplastic and immunostimulatory effects, 907–908 for cancer, cardiovascular effects, chemical composition, clinical applications, 908–909 description, 906, 907f dosage, drug interactions, history and folk use, for hypertension, for immune support, 908–909 pharmacology, 907–908 toxicity, Viscum album coloratum, Vishnu (god of protection), Vision (Fire), Visual contrast sensitivity testing (VCS), for mold expo- sure assessment, Vital force, of life, 22, 82, Vitalism, 81–82 meaning of symptoms in, versus mechanism, 80–81 Vitamin A (retinol), 910–918.e2 for acne vulgaris/acne conglobata treatment, 1058–1059 for alcohol detoxification/treatment, 1085–1086 antioxidant potential of, 447t carotenoids to, conversion of, for cataracts, for cervical dysplasia, clinical applications, 916–917 for Crohn’s disease, deficiency of, 911–912 determination of, immune system effects, xerophthalmias, 912, 912t dietary sources, 911, 911t distribution in human tissue, 914t dosage, drug interactions, for dry eyes, for female infertility, for fibrocystic breast disease (FBD), Vitamin A (retinol) (Continued) food sources for, 444t forms of, 910f–911f for hepatitis viruses, for HIV/AIDS, 917, 1384b for hyperthyroidism/Graves’ disease, immune support by, for infections, 916–917 for infectious diarrhea, 1425–1426, interaction of vitamin K with, for leukoplakia, 1528–1529 for lichen planus, 1531–1532 life stages recommendations, 911t for male infertility, for measles, for menorrhagia, metabolism of, 912–914, 913f–915f absorption, conversion of beta-carotene to, 913–914 transformation in intestinal mucosa, transport, storage, and excretion of, 912–914 nomenclature, non-provitamin A carotenoids, 444t for osteoarthritis, 1628, for otitis media, for parasitical infections, for peptic ulcer disease, for periodontal disease, physiologic roles of, 914–916 epithelial tissue maintenance and development, growth and development, immune function, reproductive function, 915–916 vision, 914–915 for pneumonia and bronchitis, potential applications of, provitamin A carotenoids, 444t recommended dietary allowance, 910–911, 911t for respiratory syncytial virus, 916–917 for seborrheic dermatitis, for skin disorders, status determination of, 180–181 toxicity, 917–918 toxicology of, 948–950 for vaginitis, Vitamin A single-nucleotide polymorphism, Vitamin B, for Parkinson’s disease, Vitamin B complex, for alcohol detoxification/treatment, 1086–1087 for female infertility, for insomnia, for menorrhagia, for rosacea, Vitamin B supplementation, for carpal tunnel syndrome, 1204 Vitamin B 1 (thiamine) for Alzheimer’s disease, for congestive heart failure, for female infertility, for HIV/AIDS, 1384b Vitamin B 2 (riboflavin) for cataracts, 1810–1811 for female infertility, for migraine headaches, 1581, 1581f, for osteoporosis, Vitamin B 3 (niacin) affective disorders and, for diabetes management, for gout, for hepatitis viruses, for lowering cholesterol levels, 1140–1142, 1140t–1141t for osteoporosis, side effects of, 1141–1142 toxicology of, for urticaria (hives), Vitamin B 6 (pyridoxine), for acne vulgaris/acne conglobata, for asthma treatment, for cervical dysplasia, for diabetes management, for epilepsy, 1301–1302, for female infertility, 1446–1447 for HIV/AIDS, 1384b for hypertension, Vitamin B 6 (pyridoxine) (Continued) immune support by, 1013–1014 kidney stone formation and, 1522–1524 for migraine headaches, 1582f, for osteoarthritis, 1628, for osteoporosis, for Parkinson’s disease, for premenstrual syndrome, 1743, for rheumatoid arthritis, for seborrheic dermatitis, 1804–1806 status determination of, toxicology of, Vitamin B 6 single-nucleotide polymorphism, Vitamin B 9 (folic acid), for cervical dysplasia, 1217, for female infertility, for gout, 1352–1353 for hypertension, immune support by, for infectious diarrhea, 1426, for inflammatory bowel disease, for male infertility, 1468, for osteoporosis, for periodontal disease, serum folate, toxicology of, 952–953 Vitamin B 12 (cyanocobalamin), for Alzheimer’s disease, 1095–1096 for asthma, for cervical dysplasia, -deficiency anemia, 1102–1103, 1103f supplements for, deficiency of, for female infertility, for HIV/AIDS, 1384b immune support by, for infectious diarrhea, 1426, for inflammatory bowel disease, for male infertility, 1468, oral versus injectable, 1106–1107 for osteoporosis, for Parkinson’s disease, for PCOS, 1700–1701 for sarcopenia, status determination of, toxicology of, for urticaria (hives), Vitamin C (ascorbic acid), for acne vulgaris/acne conglobata treatment, for alcohol detoxification/treatment, as antioxidants, 738, for asthma, 1125–1126 atherosclerosis and, for cancer, for cardiovascular disease, for cataracts, 738, 1809, for as cell response modifier, for cervical dysplasia, 1216–1217, for chronic fatigue syndrome, for chronic kidney disease, 1514–1515 for constipation, deficiency of, for diabetes, for diabetes management, for endometriosis, for female infertility, for glaucoma, 1345, for gout, for hemorrhoids, for hepatitis viruses, 1362, for HIV/AIDS, 1385b for hypertension, 738, immune support by, for inflammatory bowel disease, kidney stone and, for leukoplakia, for male infertility, 1465–1466, for menopause, for menorrhagia, for multiple sclerosis, for neurodegeneration, for osteoarthritis, 1627, for osteoporosis, 1655–1656 for otitis media, for pelvic inflammatory disease,

# I-50INDEX

Vitamin C (ascorbic acid) (Continued) for periodontal disease, 1691–1693 for pneumonia and bronchitis, in pregnancy, 1736–1737 for rheumatoid arthritis, scurvy, for streptococcal pharyngitis (strep throat), 1815–1816 toxicology of, for vaginitis, Vitamin D for asthma, attention deficit hyperactivity disorder (ADHD) and, 1160 for benign prostatic hyperplasia, boron and, for chronic kidney disease, for epilepsy, for female infertility, 1447–1448 for inflammatory bowel disease, interaction of vitamin K with, 936, for male infertility, for osteoarthritis, 1627, 1628f, 1628t for Parkinson’s disease, 1670–1671 for PCOS, 1702–1703 for periodontal disease, 1692–1693 in pregnancy, 1737–1738 status determination of, toxicology of, 950–951 for uterine fibroids, 1836, 1837f for vaginitis, Vitamin D binding protein, Vitamin D deficiency, Vitamin D hypersensitivity, Vitamin D single-nucleotide polymorphisms, Vitamin D 2 /calcitriol, for acne vulgaris/acne conglobata, affective disorders and, for hepatitis viruses, 1363, for HIV/AIDS, 1384b, for hyperthyroidism/Graves’ disease, immune support by, for multiple sclerosis, for osteoporosis, for premenstrual syndrome, 1744, for psoriasis, 1764–1766 for rheumatoid arthritis, for sarcopenia, 1793, 1799–1800 Vitamin D 3 (cholecalciferol) for multiple sclerosis, for osteoporosis, for Parkinson’s disease, Vitamin deficiencies, lichen planus and, Vitamin E (tocopherols) for acne vulgaris/acne conglobata treatment, as antioxidants, 738–740 gamma-tocopherol, tocotrienols, 739–740 for asthma, atherosclerosis and, 1143–1144, 1143t–1144t for atopic dermatitis (eczema), for cancer, for cardiovascular disease, for cataracts, as cell response modifier, for cervical dysplasia, for chronic fatigue syndrome, for chronic kidney disease, deficiency of, for diabetes, management, for endometriosis, for epilepsy, 1303, for female infertility, for fibrocystic breast disease (FBD), 1315–1316 for hepatitis C and E viruses, 1362, for herpes simplex virus, for HIV/AIDS, 1384b immune support by, for immunity, for inflammatory bowel disease, 1481, interaction of vitamin K with, for leukoplakia, for male infertility, 1466, for menopause, Vitamin E (tocopherols) (Continued) for menorrhagia, mortality risk and, 749–750 for neurodegenerative disease, for osteoarthritis, for PCOS, for peptic ulcer disease, 1686, for periodontal disease, for pneumonia and bronchitis, in pregnancy, 1736–1737 for premenstrual syndrome, 1744, for rheumatoid arthritis, for sarcopenia, status determination of, toxicology of, for vaginitis, 1844–1845 for xenobiotic receptor activation, 943f Vitamin K, 919–947.e5 average intake (Dutch population), 924t for cardiovascular health, 937–941 complementary interventions with, current RDI versus expanded criteria for, 945–946 deficiency of, for dental bone support, description of, disappointing and conflicting results of, 935–936 dosing considerations of, 945–947 effect of dosage, 923–924 effects of MK-7 on raising bone content of, forms, sources, absorption, and metabolism of, 919–924, 920f for inflammatory bowel disease, inflammatory modulation by, interactions with other vitamins, 939, 943–944 interactions with pharmaceuticals, 943–944 kidney stone formation and, for menorrhagia, for oral health, for osteoarthritis, 1628–1629, for osteoporosis, 1653–1654 recycling and carboxylation reactions of, 925f role in bone health of, 926–937, 926f safety of, single-nucleotide polymorphisms, status biomarkers, 944–945 status determination of, 181, 944–945 toxicology of, 951–952 xenobiotic receptor activation, 943f Vitamin K 1 (phylloquinone or phytomenadione), 919–924 in bone mineral density, 927, 929t–930t for cancer treatment, 941–942 chemical composition of, 920f conversion to K 2 of, 921–922 dosages of, for osteocalcin activation, 927, 928t–930t, 932t–933t food sources of, 922t forms, sources, absorption, and metabolism of, on fracture rate, 927–934, 929t–930t interventions with, 927, 929t–930t on markers of bone metabolism, mechanism of action of, 924–926 for prevention, Vitamin K 2 (menaquinones) on bone mineral density, on bone strength and quality, for cancer treatment, chemical composition of, 920f compared to bisphosphonates, conversion to K 1 to, 921–922 dosages of for osteocalcin activation, 927, 928t–930t, 932t–933t in supraphysiological range, 933t, 934–935, 935f evolutionary intake of, food sources of, 922t–923t forms, sources, absorption, and metabolism of, 919–924 hydrolyzed collagen protein and, interventions with, 929t–930t, 932t, on markers of bone metabolism, mechanism of action of, 924–926 for prevention, 946–947 role in bone health and osteoporosis, 926–937, 926f sources of, 920–922 supplement forms and doses of, 923–924 therapeutic dosage of, 946–947 Vitamin K 3 (menadione) for cancer treatment, 941–942 chemical composition of, 920f forms, sources, absorption, and metabolism of, 919–924 occurrence and properties of, Vitamin toxicity, 948–954.e3 laboratory tests for, 954, 954t Vitamins/vitamin supplement for cataracts, fat-soluble vitamin status, 180–181 fat-soluble vitamins, for HIV/AIDS, 1389–1390 for hypothyroidism treatment, 1419–1420 for inflammatory bowel disease, 1481–1482, 1483t for multiple sclerosis, in pregnancy, 1725, 1726t–1729t for premenstrual syndrome, for rheumatoid arthritis (RA), for sports nutrition, 1038–1039 status determination of, 178–180, 179t water-soluble vitamin status, 178–180 water-soluble vitamins, 952–954 Vitex agnus castus (chaste tree or berry), 955–958.e1, 956f chemical composition of, 955, 956f for corpus luteum insufficiency, 956, 957t description of, dosage of, drug interactions of, efficacy of, 957t for endometriosis, for female infertility, 1450–1451 for fibrocystic breast disease (FBD), history and folk use of, for hyperprolactinemia, for infertility and secondary amenorrhea, for menorrhagia, for PCOS, 1704–1705 pharmacology of, 955, 956f for premenstrual syndrome, and cyclic mastalgia, 956–958, 957t side effects of, 958t toxicology of, Vitex vinifera (grape seed skin), Vitexin-4’-rhamnoside, 544f Vithoulkas, George, definition of health, Vitis vinifera (grape seed) for cataracts, for inflammatory bowel disease, for macular degeneration, for periodontal disease, for varicose veins, Vivisection, VMA. See Vanilmandelic acid VOCs. See Volatile organic compounds Volatile oils, 414, 1224–1225, Volatile organic compounds (VOCs), Vomiting, Cannabis for, 475–476 von Willebrand factor (vWF), 350–351, 352f VPBs. See Ventricular premature beats VTE. See Venous thromboembolism Vulvodynia, 1840–1849.e4, Vulvovaginal candidiasis, 1842–1843, 1843f, 1843b Vulvovaginitis, 1840–1849.e4 vWF. See von Willebrand factor

# W

Walking, as exercise, 282, Walnuts, for atherosclerosis, Wardwell, Walter, 42–43 Warfarin, 940–941 coenzyme Q 10 and, Warts, anogenital, Washington, George, Washington Lecture Association, Wasting syndrome, 1387–1388, 1387b Water basic properties of, for gallstone treatment, Kaph (biologic water), physiologic effects of, 317–320 taste, temperature on fever,

# I-51INDEX

Water-Cure Journal, Water-damaged buildings, mold exposure and, 209–211, 210t–212t Water-holding capacity, of fiber, Water intake, absorption of, conditions improved by, 963–964 asthma and allergies, coronary heart disease and fatal myocardial infarc- tion, 963–964 migraine headache, peptic ulcers and dyspepsia, weight loss, dehydration causes of, jet lag and, multiple-organ-system effects of, signs/symptoms, subclinical (hypohydration), factors influencing, during fasting, in fasting, hydration for athletes and laborers, cognitive-motor function and, effect on blood flow of, 962–963 for elderly, of fatty acids, for infectious diarrhea, special needs, in winter, ideal, 960–961 metabolism of, 961–962 cell hydration and behavior, oxygen transport, protein structure and function, versus other beverages, roles to the body of, 959–960 sources of water, temperature of water, thirst, 370, 960–961 water loss portals, water versus other beverages, for weight reduction, Water-only fasting, Water-soluble vitamin status, assessment of, 178–180 Water-soluble vitamins, 949t, 952–954 vitamin B 3 (niacin), vitamin B 6 (pyridoxine), vitamin B 9 (folic acid), 952–953 vitamin B 12 (cobalamins), vitamin C (ascorbic acid), Water supply, U. S., Weight balance, 1440–1441 Weight control, Weight loss. See Dieting/weight loss Welch, William, Wellness (Unani medicine), Weltmer, Sidney, Wendel, Hugo R., Wernicke encephalopathy, Westergren method, 122, 122b Western Diseases (Burkitt and Trowell), Western Health Reform Institute, Wet sheet pack, 326–327 Whey protein, 1046–1047, 1362, White blood cells/macrophages, 163, White fat, WHO. See World Health Organization Whole-body interventions, 6–7 Whole-foods diet, balanced, Whole grains, 1873, 1873t Whorton, James, 28, on hygienic movement, on transition to professionalized naturopathy, Wild indigo. See Baptisia tinctoria Wild-caught fish, farmed versus, 594–595, 595f Williams, Roger, Willow bracket, 689, 689f Wilson disease, Wintrobe method, 122, 122b Witch hazel (Hamamelis virginiana), Witch’s butter (Tremella fuciformis, Tremella aurantia, Tremella mesenterica), Withania somnifera, 1471–1472 Withdrawal, from alcohol, Wnt pathway, 1642f Woerishofen facility, Women, soy protein effects on, Women’s issues hysterectomy, ideal water intake, idiopathic cyclic edema, ovarian cancer, as risk factors for osteoporosis, symptoms of urinary tract infections in, 1251t “Working Definition of Naturopathic Nutrition”, 14–15 World Health Organization (WHO), 189, mold exposure assessment and, Wormwood. See Artemisia absinthium Wound healing, Aloe vera (Cape aloe) for, 424–425 boron for, Centella asiatica (Gotu kola) for, diabetes-related poor, in diabetic patients, 1274, Hypericum perforatum (St. John’s wort) for, 674–675

# X

Xanthoxylum americanum (prickly ash), Xanthurenic acid, Xenobiotic metabolizing enzymes (XMEs), Xenobiotic pollutants, exposure to, intestinal permeabil- ity and, 173–174 Xenobiotics, 270t, 735, 943f, 1351–1352, 1769–1770 Xenoestrogens endometriosis and, exposure, 1459–1460 Xerophthalmias, 912, 912t Xerostomia, coenzyme Q 10 and, XMEs. See Xenobiotic metabolizing enzymes Xylene, 218t–219t exposure, Xylitol,

# Y

Yamabushitake, 686–687, 686f Yarrow (Achillea millefolium), Yeast ASD and, 1177–1178 beta-glucans, foods containing, for immune support, markers of, 237–239 Yeast Connection, The (Crook), Yeast infections, of gastrointestinal tract, Malassezia, vaginal, yeast syndrome, Yersinia enterocolitica, Yin and Yang forces, Yoga, 23, 100, 1203, for affective disorders, multiple sclerosis and, Young individuals, vitamin K support, Youngest Science (Thomas), Yucca, 1629, Yun Zhi, 683f “Yungborn”, Yunnan Baiyao,

# Z

Zang Fu, Zeaxanthin, 444f Zinc, 203–204, 741–742, 1014, for acne vulgaris/acne conglobata, 1059–1060 for alcohol detoxification/treatment, as antioxidant, for ASD, attention deficit hyperactivity disorder (ADHD) and, 1160 for benign prostatic hyperplasia, for cataracts, for cervical dysplasia, for Crohn’s disease, for diabetes management, for epilepsy, 1303, for erythema multiforme, for female infertility, hair mineral analysis for, for hepatitis C, for herpes simplex virus, for HIV/AIDS, 1384b for infectious diarrhea, 1426, for inflammatory bowel disease, for male infertility, 1467–1468, melatonin and, for type 2 diabetes, for osteoarthritis, 1628, for osteoporosis, 1648–1650 for otitis media, for PCOS, for peptic ulcer disease, 1686, for periodontal disease, in pregnancy, for premenstrual syndrome, 1744, for rheumatoid arthritis, for rosacea, for vaginitis, zinc/copper ratios, Zinc Paradox, Zinc protoporphyrin (ZPP), Zingiber officinale (ginger), 965–970.e2, 875, 1353 analgesic effects, antibiotic activity, anticancer effects, 967–968 antioxidant effects of, antiulcer effects, cardiotonic and hypotensive properties of, chemical composition of, 965, 966f cholesterol-lowering and hepatic effects of, for chronic kidney disease, 1516–1517, 1517f description of, 965, 966f dosage of, drug interactions of, gastrointestinal smooth muscle effects, history and folk use of, for inflammatory disorders, 969–970 insulin and blood glucose effects on, for menorrhagia, 1572–1573 for migraine headaches, 1583–1584, for motion sickness, 968–969 for nausea and vomiting, for osteoarthritis, for peptic ulcer disease, pharmacology of, 966–968 platelets and fibrinolysis, effects on, 966–967 prostaglandin and leukotriene metabolism, effects on, for rheumatoid arthritis (RA), thermogenic properties of, toxicology of, Zizyphi fructus (jujube plum), Zolpidem, melatonin with, “Zone therapy”, Zonula adherens, Zonula occludens, 168–169 Zonulin, celiac disease and, 1207–1208, 1208f, 1208t ZPP. See Zinc protoporphyrin Zung’s self-rating depression scale,
